_:Nf3d25589d44449fda7a9282f1c834cdc <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15021891> .
<http://www.openbel.org/bel/p_EGID_5424> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//5424> .
<http://www.openbel.org/bel/complex_NCR_Nfkb_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ModifiedProteinAbundance> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress_Increases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_S_780> <http://www.openbel.org/vocabulary/hasModificationType> <http://www.openbel.org/vocabulary/PhosphorylationSerine> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
_:N7a09e7bd1d464289b2e82114d3ffd01d <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_ROCK2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:ROCK2)" .
<http://www.openbel.org/bel/p_EGID_2475> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK1))" .
<http://www.openbel.org/bel/bp_GO_cell_growth> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_SCHEM_Sirolimus> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nfa1009b83fa74bdfa8c1a4853a5f3c98 .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:CDKN1B),p(HGNC:CDK2),p(HGNC:CCNB1))" .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Sirolimus> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_SKP2> .
_:Nfe6b9fc05c38404a9768fcef6fe603d0 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nbfa807e779c245489c621cd74e5b68e5 <http://www.openbel.org/vocabulary/hasEvidenceText> "Modified assertion" .
_:N648dc396fdc24ea2a04b2d595f383f8f <http://www.openbel.org/vocabulary/hasEvidenceText> "Inhibition of c-myc expression may partially reverse the resistance of MCF-7/Adr against doxorubicin, suggesting that c-myc may be involved in the mechanism of drug-resistance of tumor cells. " .
<http://www.openbel.org/bel/tscript_p_RGD_Myc_Increases_bp_MESHPP_Apoptosis> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(RGD:Myc)) increases bp(MESHPP:Apoptosis)" .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:N690e05d73f194492ae44aa58eec8ee97 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N4f9ed8d0384e4c9ab74ffa05dc267cbf .
_:Nc68955fa98934da0aa220541b5f9336d <http://www.openbel.org/vocabulary/hasEvidenceText> "Interestingly, cell treatment with potent serine-threonine-phosphatase inhibitors, calyculin A or okadaic acid, prevented the regulation of both histone H1(0) and c-myc gene expressions by sodium butyrate." .
<http://www.openbel.org/bel/p_HGNC_CDKN1A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Ne544f6d3246c4c0dab86782d56fad5e8 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10508165> .
<http://www.openbel.org/bel/a_CHEBI_ceramide_Decreases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Nd91b2ea4b1664798b1ba52a351679a82 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P_DirectlyIncreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
<http://www.openbel.org/bel/p_HGNC_MXI1_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MXI1) decreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family_Increases_r_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MAX> .
<http://www.openbel.org/bel/p_PFH_RAF_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Na98752b5db4e47bf9bab6d2e9149f448 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15358814> .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40_DirectlyDecreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nd84b73e335c649f18bf475105af33b03 .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:\"D-Glucose, anhydrous\")" .
<http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_lovastatin> .
<http://www.openbel.org/bel/bp_GO_glycolysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nb5563ff8e8b54adb9469097102d70b07 <http://www.openbel.org/vocabulary/hasEvidenceText> "The c-Myc oncoprotein regulates transcription of genes that are associated with cell growth, proliferation and apoptosis." .
_:N9d5da96e083e4321b246f785ec11de5b <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_MAPK1_Increases_tscript_p_HGNC_MYC> .
_:Nce4ece696d424c3cbb74627e43ce56fa <http://www.openbel.org/vocabulary/hasEvidenceText> "The biological activity of u-PA, t-PA, as well as that of limiting concentration of FCS (1%), was mediated by PTK and PKC." .
<http://www.openbel.org/bel/p_HGNC_GSK3B> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_ceramide_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nb7dbd5320a3d405eabcb34d4ed955d8a .
_:N6a8bc81eb3444139a60f4aa73b284a8f <http://www.openbel.org/vocabulary/hasEvidenceText> "STAT molecules conventionally require both a conserved tyrosine phosphorylation site and a C-terminal TAD to mediate transcription. c-myc is induced in an immediate-early fashion, suggesting that Stat5 may interact directly with promoter of this gene rather than via an intermediary transcription factor." .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/kin_p_MGI_Stk11_Decreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:N555ffda1fd51462eb070a86fb398a693 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_GSK3B> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:GSK3B)" .
<http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Nc6803fc006034e12bc5bf37b359855c6 .
<http://www.openbel.org/bel/p_HGNC_NFYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_DirectlyIncreases_p_HGNC_MYC_pmod_P_T_58> <http://www.openbel.org/vocabulary/hasEvidence> _:N76ac5b7fd6d944918e7df5fcb23ce536 .
_:N6df102a43ca3429abb919162b7cd1be0 <http://www.openbel.org/vocabulary/hasEvidenceText> "Table 6 Genes up-regulated or down-regulated by one or more of the compounds [ICI, Ral or trans-hydroxytamoxifen (TOT)-1 \u00B5M] but not by E2 (10 nM)" .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_PFH_PRKC_Family> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc_Increases_bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasEvidence> _:Nb7b63b8575cc4bf29e72d1414150e53a .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_58> <http://www.openbel.org/vocabulary/hasModificationType> <http://www.openbel.org/vocabulary/PhosphorylationThreonine> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex> .
<http://www.openbel.org/bel/p_MGI_Stk11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_RBX1> .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex_Increases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family_Increases_r_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(PFM:\"Akt Family\")) increases r(MGI:Myc)" .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> .
<http://www.openbel.org/bel/p_HGNC_CTCF> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CTCF> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_RGD_Myc> .
<http://www.openbel.org/bel/p_MGI_Il4ra> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_tscript_p_HGNC_MYC_pmod_P> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_ROCK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nc0c83a8b4060423fa6b4be26e87ef4ac <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:17974917> .
<http://www.openbel.org/bel/p_HGNC_HIF1A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_CHEBI_simvastatin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CDK2> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(complex(p(HGNC:MYC),p(HGNC:MAX)))" .
_:N404334d1c59844e187533083267e7bd3 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18046334> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P))" .
<http://www.openbel.org/bel/p_HGNC_MXI1_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MXI1> .
_:N991a55aa89994d4ea481e3a143feb4e4 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_BCL2L11> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:BCL2L11)" .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(PFM:\"Stat5 Family\")) increases r(MGI:Myc)" .
<http://www.openbel.org/bel/bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//cell%20proliferation> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Ncd484cf247514b63b5b2570c63ed7e03 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11344222> .
<http://www.openbel.org/bel/a_CHEBI_cisplatin> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:cisplatin)" .
_:N9ad974896fae4850ad39640dbce741e3 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_DirectlyIncreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:simvastatin) increases r(MGI:Myc)" .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
_:Nf133596cb14b48c89315c64bb004bc00 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_58> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_mifepristone_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nf75048be6fa64a108a04ad5ab0849a41 .
<http://www.openbel.org/bel/tscript_p_MGI_Myc_Increases_bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_p_HGNC_MYC_pmod_P> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N1e07c28a80644063b64f6213446312f3 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_ATF2_pmod_P_T_51> .
<http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_S_780> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:RB1,pmod(P,S,780))" .
<http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_SKP2> .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_HIF1A> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_glycolysis> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N59eea53535ba43419700e74131aa366a <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N6d1fd7c61a6f4dcd9a11bc84226ce633 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/complex_NCH_p85/p110_PI3Kinase_Complex> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/complex_p_HGNC_MNT_p_HGNC_MAX> .
<http://www.openbel.org/bel/p_HGNC_SNIP1_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N76753b3dfcbf442cb26076f384561ac6 .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_KITLG> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/cat_p_HGNC_KITLG> .
_:N54c58219c4da4202a8f5ebfba33222bb <http://www.openbel.org/vocabulary/hasEvidenceText> "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway \u2014 for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-D\u2013Cdk4 from phosphorylating Rb \u2014 unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 4\u20136,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B." .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(MGI:Il4),p(MGI:Il4ra))" .
<http://www.openbel.org/bel/p_HGNC_ROCK1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_ceramide_Decreases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:ceramide) decreases p(HGNC:MYC)" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_TNFRSF10A> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_MGI_Myc> .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex_DirectlyIncreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
_:N2cb4acffb5d64d91b5a00ee44dca98af <http://www.openbel.org/vocabulary/hasEvidenceText> "Figure 1 | The ErbB signalling network." .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_MAPK3> .
<http://www.openbel.org/bel/a_CHEBI_ceramide> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N00a98f5d04cd47d5bda1c6a9eeb72d6c .
_:N4e1ccbf0fc994101a992ceb90cf432c0 <http://www.openbel.org/vocabulary/hasEvidenceText> "Linoleic acid induces DNA synthesis, c-fos, c-jun, and c-myc mRNA expression and MAPK activation in VSMC." .
_:N8d1ddfc4ebc34fa78cd22c6920f29de5 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> .
_:Ne67695a0f36e49b78e704d67e2f6ccd4 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//SKP2> .
<http://www.openbel.org/bel/p_MGI_Il4> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Il4> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.openbel.org/vocabulary/hasEvidence> _:Nf6e71c69e6ca4c44a4d2190c54b15561 .
<http://www.openbel.org/bel/p_PFM_Foxo_Family> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Foxo%20Family> .
_:N1bf5cabc1ef24aef8540926d8edcb184 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_quercetin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_SKP2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases cat(p(HGNC:SKP2))" .
_:Nd4657abd7a5845c2bbbd4427c19af3aa <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N54c58219c4da4202a8f5ebfba33222bb <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12209154> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:SRC)) increases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/tscript_p_HGNC_MNT> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex_DirectlyIncreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ncdb783d15692446791fcec50f914b8d4 .
_:N589e51e4d3874940a9bcb19e3ecb3510 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_nicotine_Increases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_MGI_Il4> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Il4)" .
_:N7a1c8b294ce14549bd691dbf021859e1 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Na98752b5db4e47bf9bab6d2e9149f448 .
_:Ncd371260ae5c453798f358a0c6a3da8e <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_CHEBI_calcitriol_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N7a1c8b294ce14549bd691dbf021859e1 .
<http://www.openbel.org/bel/p_HGNC_MAPK3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/bp_MESHPP_Apoptosis> <http://www.w3.org/2000/01/rdf-schema#label> "bp(MESHPP:Apoptosis)" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/kin_p_HGNC_CDK2> .
<http://www.openbel.org/bel/p_MGI_Pim1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_calcitriol_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_calcitriol> .
<http://www.openbel.org/bel/p_PFH_SMAD_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N2964e0175fd0472bb9b07b985d46c280 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10508165> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P,T,358))" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases bp(GO:\"G1/S transition of mitotic cell cycle\")" .
<http://www.openbel.org/bel/p_HGNC_CDKN1A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Tgfb1) decreases p(MGI:Myc)" .
<http://www.openbel.org/bel/p_HGNC_HIF1A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nfa1009b83fa74bdfa8c1a4853a5f3c98 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_RGD_Pax4> .
<http://www.openbel.org/bel/a_SCHEM_Calcium> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Calcium> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
<http://www.openbel.org/bel/p_HGNC_RPL11_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N6f6b239300ec4eaebf127678482c805f <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12209154> .
<http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14_Increases_tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_complex_p_HGNC_MYC_p_HGNC_MAX> .
<http://www.openbel.org/bel/a_CHEBI_nicotine_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N589e51e4d3874940a9bcb19e3ecb3510 .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_glycolysis> <http://www.openbel.org/vocabulary/hasEvidence> _:Nba42f14b886b47ce9309e4fb31728883 .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Decreases_tscript_p_HGNC_MNT> <http://www.openbel.org/vocabulary/hasEvidence> _:N44f8154ac7d04538b58a853d2bba45f8 .
_:Nd926613b585a4c58a579e66ac535037f <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_HIF1A_Decreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC_Increases_p_HGNC_CDKN1A> <http://www.openbel.org/vocabulary/hasEvidence> _:Ndd6d70c4f9ef42348214e7e33692b781 .
<http://www.openbel.org/bel/p_HGNC_CDKN2A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:N504fd9010a0a4f448ce9a271465d15fe <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_PAK2> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_58> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P,T,58))" .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:N9ad974896fae4850ad39640dbce741e3 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14757441> .
_:N1bf5cabc1ef24aef8540926d8edcb184 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_MGI_Il4ra> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Il4ra)" .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N555ffda1fd51462eb070a86fb398a693 .
<http://www.openbel.org/bel/kin_p_HGNC_SRC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/p_MGI_Pdgfb> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family_Decreases_tscript_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
_:Nc6803fc006034e12bc5bf37b359855c6 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9569019> .
<http://www.openbel.org/bel/p_HGNC_GSK3B> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nb65b6a9148874c2cb5c45f7480c88c84 .
<http://www.openbel.org/bel/bp_GO_response_to_heat_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N61c5f80ad33541dc86cde49e3032f7cb <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(PFH:\"SMAD Family\"))" .
<http://www.openbel.org/bel/a_CHEBI_troglitazone> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N92c663f74d154e1e8399f14d1c119ade .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_MAPK1> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1_Increases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:CSNK2A1)) increases p(HGNC:MYC)" .
_:Nfe6b9fc05c38404a9768fcef6fe603d0 <http://www.openbel.org/vocabulary/hasEvidenceText> "c-MYC-mediated transformation. By expression profiling, the metastasis-associated protein 1 (MTA1) gene was identified here as a target of the c-MYC oncoprotein in primary human cells, a result confirmed in human cancer cells." .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_PFM_Foxo_Family> .
_:Nc63dbab7e50b4d019376214a8b01e545 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nb7dbd5320a3d405eabcb34d4ed955d8a <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Ne67695a0f36e49b78e704d67e2f6ccd4 <http://www.openbel.org/vocabulary/hasEvidenceText> "Approximately 6-12 hours after treatment with okadaic acid, mRNA levels of c-myc, p34cdc2, and p58GTA, two cell cycle regulated protein kinases, decrease. Okadaic acid inhibits the growth of U937 cells, induces changes in nuclear morphology, stimulates increases in Mac-1 and Leu 11 surface antigens, and induces these cells to produce superoxide. These changes, taken together, suggest that U937 cells have been induced by okadaic acid to differentiate towards a more mature cell type." .
_:Nb7b63b8575cc4bf29e72d1414150e53a <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nf5e8af358b43401584456575f9257671 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ne53720177d19481684179086b66d1826 .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_DNA_replication> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:RBX1),p(HGNC:SKP2)) increases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/a_CHEBI_troglitazone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:N92c663f74d154e1e8399f14d1c119ade <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16204065> .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:Nf7374451a7004cabb76a06f13c45aefd <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:19029933> .
<http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasEvidence> _:Nab5656c22f054e01bfdce740e2cfacc4 .
_:N1db0146e2ed34be1a5e5b9734bd3e990 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/path_SDIS_laminar_shear_stress_Increases_r_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N1bf5cabc1ef24aef8540926d8edcb184 <http://www.openbel.org/vocabulary/hasEvidenceText> "Table 1. Differentially expressed genes in KMS-26 enzastaurin-treated cells" .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_EGFR> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc_Increases_bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_RGD_Myc> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Myc,pmod(P))" .
_:N861eff9ccc14484cac0223d99b2c742b <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15356269> .
<http://www.openbel.org/bel/bp_GO_cell_growth> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"cell growth\")" .
<http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N90ae420ed2af403a80cc85d60a763c84 .
<http://www.openbel.org/bel/p_HGNC_CDKN1B> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_PFM_Akt_Family> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Akt%20Family> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/p_EGID_2475> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_ROCK1> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyDecreases> .
<http://www.openbel.org/bel/p_HGNC_RBX1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_ROCK1> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK2> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
_:Nb948ad18b56c4f8092149f85b8ebba58 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11274345> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/tscript_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_PFH_SMAD_Family> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:PAK2))" .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(complex(p(HGNC:MNT),p(HGNC:MAX))) decreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> .
<http://www.openbel.org/bel/complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
_:N4e1ccbf0fc994101a992ceb90cf432c0 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:N80f1328034b84745a8d8c7bdb891842e <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_cycle> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases bp(GO:\"cell cycle\")" .
_:Nf6e71c69e6ca4c44a4d2190c54b15561 <http://www.openbel.org/vocabulary/hasEvidenceText> "Surprisingly, Skp2 enhances c-Myc-induced S phase transition and activates c-Myc target genes in a Myc-dependent manner." .
<http://www.openbel.org/bel/p_HGNC_EGFR> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Nccbe5facd42a4c4986b9ffaf6125ac61 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_RPL11_Decreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2> .
_:N988ed9057f6143b9b4c5764238499138 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MXI1_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_PFH_IFNA_Family> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//IFNA%20Family> .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_MGI_Jup> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Jup> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex_Increases_r_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_MGI_Stk11> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(MGI:Stk11))" .
_:N690b4bc8be04411cae73180bb765d47b <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:1555236> .
_:N80f1328034b84745a8d8c7bdb891842e <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18268536> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N8b93def31af64fc381e5e80a614a4f52 .
_:N96892952b7fe40afaa317426816bc84f <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> .
_:N4f1cb21104a64cf8af17702a53851d22 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_SKP2> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nf3d25589d44449fda7a9282f1c834cdc .
<http://www.openbel.org/bel/p_HGNC_HOXB13> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Ncd371260ae5c453798f358a0c6a3da8e <http://www.openbel.org/vocabulary/hasEvidenceText> "Stat5 mediates c-myc, bcl-2, and bcl-x mRNA induction through its TAD." .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_HIF1A> .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch_Increases_tscript_p_RGD_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N1aaa6a8b46dc4c76a4532df7178d2d43 .
<http://www.openbel.org/bel/p_HGNC_HOXB13> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:N26a979e9013545c7ae735eb91da0b474 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9715279> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/bp_GO_glycolysis> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//glycolysis> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_EGID_5243> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_MGI_Myc> .
<http://www.openbel.org/bel/p_HGNC_CUL1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CUL1> .
_:N30a68934867f4b448b158b94f339afd7 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(RGD:Myc))" .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N0f10fce3502e4fffbc40529f64a83f52 .
_:N1562ff788316497a9c6f77a7c3d0b751 <http://www.openbel.org/vocabulary/hasEvidenceText> "Table S2. Other responsive genes are deregulated by enzastaurin in U251, as detected by Anova and Ingenuity Pathway Analysis software, shown in Tables S2 and S3 respectively. U251 cells were treated in triplicates with 10?M enzastaurin for 4 hours. The initial gene expression analysis data files (CEL files) were generated using Affymetrix GeneChip Operating Software (GCOS) version 1.2. CEL files were processed as described earlier (11). p-value 0.001 and 1.5-fold change were applied as thresholds to select up- or down- regulated probes." .
<http://www.openbel.org/bel/p_HGNC_HNRNPK_Increases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:HNRNPK) increases r(HGNC:MYC)" .
<http://www.openbel.org/bel/a_CHEBI_quercetin_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/bp_GO_cell_growth> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//cell%20growth> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Decreases_tscript_p_HGNC_MNT> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_growth> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/cat_p_HGNC_SKP2> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_DNA_replication> <http://www.openbel.org/vocabulary/hasEvidence> _:N6f7d84eee3ae4a539598fb6c5868f4e1 .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:HIF1A))" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_KITLG> <http://www.openbel.org/vocabulary/hasEvidence> _:N8dd9acc9a4ab4d18be18d81932c22166 .
<http://www.openbel.org/bel/complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N8b93def31af64fc381e5e80a614a4f52 <http://www.openbel.org/vocabulary/hasEvidenceText> "we next investigated target genes of b-catenin, in particular, c-Jun, c-Myc, and cyclin D1, and their possible contribution to the anti-MM effect of enzastaurin. Our results show that b-catenin induces c-Jun, whereas c-Myc was markedly down-regulated #(this is protein - western blots in fig 3A)" .
<http://www.openbel.org/bel/p_HGNC_MXD1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC_DirectlyDecreases_tscript_p_HGNC_ZBTB17> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_CCNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_EGID_2475> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(EGID:2475))" .
<http://www.openbel.org/bel/bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Apoptosis> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_BCL2L11> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_BCL2L11> .
<http://www.openbel.org/bel/p_HGNC_PAK2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:PAK2)" .
<http://www.openbel.org/bel/p_HGNC_MLXIPL> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MLXIPL> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N2964e0175fd0472bb9b07b985d46c280 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> .
_:N75afbecbc875479baaee4815523f151d <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_PFH_PRKC_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N4f9ed8d0384e4c9ab74ffa05dc267cbf <http://www.openbel.org/vocabulary/hasEvidenceText> "mall inhibitory RNA-induced silencing of GSK3beta prevents phosphorylation of MYC on T58, thereby inhibiting recognition of MYC by the E3 ubiquitin ligase component FBW7." .
<http://www.openbel.org/bel/p_MGI_Jup_Decreases_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_HGNC_MNT> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_KITLG> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasEvidence> _:N4f1cb21104a64cf8af17702a53851d22 .
<http://www.openbel.org/bel/r_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_PFM_Stat5_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Nfa1009b83fa74bdfa8c1a4853a5f3c98 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16633365> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_SCHEM_Estrogens> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:Estrogens)" .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(complex(NCH:\"Nfkb Complex\"))" .
_:N5a83ea4cdbf34824bc775f1392e7d380 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF_DirectlyDecreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_CTCF> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MAX> .
_:N59eea53535ba43419700e74131aa366a <http://www.openbel.org/vocabulary/hasEvidenceText> "In the p53-dependent pathway, p53 accumulates following E2F1 expression [29] through activation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) transcript p14ARF, which in turn interacts with mouse double minutes (MDM2), thereby preventing MDM2 from targeting p53 for ubiquitination and subsequent degradation" .
<http://www.openbel.org/bel/bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//cell%20cycle> .
_:N555ffda1fd51462eb070a86fb398a693 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra_Increases_p_MGI_Myc> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N7b572f44c26e4d0e98024c63906bbd2b .
<http://www.openbel.org/bel/p_HGNC_MAPK1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MAPK1)" .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_S_780> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_RB1> .
<http://www.openbel.org/bel/a_CHEBI_nicotine> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:nicotine)" .
<http://www.openbel.org/bel/p_HGNC_MXI1_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nd91b2ea4b1664798b1ba52a351679a82 .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex_DirectlyIncreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_tscript_p_HGNC_ATF2> <http://www.openbel.org/vocabulary/hasEvidence> _:N247e30732bcc41bcbc2823d914feb665 .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_ATF2_pmod_P_T_51> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:lovastatin)" .
_:N7c1828b18f1a48ad9129432b7d669dc6 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11297548> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:N03ecb4fdeb764d2da42e7cdebdbae812 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11018017> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasEvidence> _:N03ecb4fdeb764d2da42e7cdebdbae812 .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_GSK3B> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//GSK3B> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Decreases_tscript_p_HGNC_MNT> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MNT> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14_Increases_tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasEvidence> _:Nb948ad18b56c4f8092149f85b8ebba58 .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_fulvestrant> .
<http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_S_780> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ModifiedProteinAbundance> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P_DirectlyIncreases_tscript_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_quercetin_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_quercetin> .
<http://www.openbel.org/bel/a_CHEBI_nicotine_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:nicotine) increases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ModifiedProteinAbundance> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//response%20to%20hypoxia> .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:ROCK1))" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasEvidence> _:N59cd8722e1ce4fe9aba087d6f15cc645 .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_ribosome_biogenesis> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.w3.org/2000/01/rdf-schema#label> "kin(complex(NCH:\"p85/p110 PI3Kinase Complex\"))" .
<http://www.openbel.org/bel/p_HGNC_CDK3> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CDK3> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1_Decreases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:fulvestrant)" .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P_DirectlyIncreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_MGI_Myc> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia_Decreases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF_DirectlyDecreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:N5415688460f243b2a95ffe04963f4de6 <http://www.openbel.org/vocabulary/hasEvidenceText> "Adenoviral overexpression of Pax4 caused a 3.5-fold increase in beta-cell proliferation with a concomitant 1.9-, 4-, and 5-fold increase in Bcl-xL (antiapoptotic), c-myc, and Id2 mRNA levels, respectively. Accordingly, Pax4 transactivated the Bcl-xL and c-myc promoters, whereas its diabetes-linked mutant was less efficient. Bcl-xL activity resulted in altered mitochondrial calcium levels and ATP production, explaining impaired glucose-induced insulin secretion in transduced islets." .
_:Nec20c03a78ba4826942fb08ea85c9bca <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15286739> .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:\"Tetradecanoylphorbol acetate\") decreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_MGI_Stk11_Decreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_MGI_Myc> .
<http://www.openbel.org/bel/cat_p_HGNC_TNFRSF10A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
_:N6f0f4a245ce6448ab1bdf8b7ccc505a9 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9321394> .
<http://www.openbel.org/bel/a_SCHEM_Calcium_Increases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N247e30732bcc41bcbc2823d914feb665 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_tscript_p_HGNC_ATF2> .
<http://www.openbel.org/bel/p_EGID_5424> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N4e1ccbf0fc994101a992ceb90cf432c0 .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_58> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MXI1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_GSK3B> .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:N92c663f74d154e1e8399f14d1c119ade <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N1be098f802b84302aa9d55284ed8a034 <http://www.openbel.org/vocabulary/hasEvidenceText> "Overexpression of HBP1 modulated mRNA levels for myeloid-specific transcription factors C/EBPalpha, c-Myb, c-Myc, and JunB, as well as lineage-specific transcription factors PU.1, GATA-1, and RUNX1." .
<http://www.openbel.org/bel/kin_p_MGI_Stk11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MAPK14> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/kin_p_MGI_Stk11> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/p_HGNC_CCND2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MAPK14> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MAPK14> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_BCL2L11> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:Nc6803fc006034e12bc5bf37b359855c6 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:HBP1))" .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_PFH_RAF_Family> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ModifiedProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
_:N9eec22bf1a854532974c8f337a008a1e <http://www.openbel.org/vocabulary/hasEvidenceText> "Overexpression of OMgp alters PDGF signaling in fibroblasts which results in a block of mitogenic signaling. PDGF induced activation of c-Src is blocked, as is the induction of c-Myc and c-Fos, while tyrosine phosphorylation of the PDGFbeta receptor, PLCgamma1 and induction of c-Jun are intact." .
_:Ne8fa4e913ac84cd99607fd5d14d402c8 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_CDK4> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CDK4)" .
_:N0f10fce3502e4fffbc40529f64a83f52 <http://www.openbel.org/vocabulary/hasEvidenceText> "Beta Catenin" .
<http://www.openbel.org/bel/p_MGI_Il4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MAPK3> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MAPK3> .
<http://www.openbel.org/bel/p_PFM_Foxo_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:Nb65b6a9148874c2cb5c45f7480c88c84 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_RB1_pmod_P_S_780> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:Ndd59d119b4cb47dc95c01ce84efd64c1 <http://www.openbel.org/vocabulary/hasEvidenceText> "Quercetin down-regulated the expression of c-myc and Ki-ras oncogenes and led to induced differentiation and apoptosis in K562 cells." .
_:Nd926613b585a4c58a579e66ac535037f <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/complex_NCH_Nfkb_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_BHLHE40> .
_:N43bca9610845459aa0fc35e6b5e6585e <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> .
_:N40e0a75abd734a27b75f90db3110fb63 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_RB1_pmod_P_S_780> .
<http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N61c5f80ad33541dc86cde49e3032f7cb .
<http://www.openbel.org/bel/kin_p_HGNC_SRC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N8b93def31af64fc381e5e80a614a4f52 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_CHEBI_quercetin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/r_HGNC_PLD2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/complex_NCH_Nfkb_Complex> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CSNK2A1> .
<http://www.openbel.org/bel/complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MAX> .
_:N0ecb500ea2e544b7945f14233e6d2bce <http://www.openbel.org/vocabulary/hasEvidenceText> "The c-Myc oncoprotein functions as a transcription factor that can transform normal cells into tumor cells, as well as playing a direct role in normal cell proliferation." .
<http://www.openbel.org/bel/p_HGNC_MLXIPL> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/cat_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Catalytic> .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Decreases_tscript_p_HGNC_MNT> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyDecreases> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
_:Ncd484cf247514b63b5b2570c63ed7e03 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasModificationType> <http://www.openbel.org/vocabulary/PhosphorylationSerine> .
_:N2cb4acffb5d64d91b5a00ee44dca98af <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_MTA1> <http://www.openbel.org/vocabulary/hasEvidence> _:Nfe6b9fc05c38404a9768fcef6fe603d0 .
_:N68658d4f610c43e987847c3e04627376 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N76ac5b7fd6d944918e7df5fcb23ce536 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_GSK3B_DirectlyIncreases_p_HGNC_MYC_pmod_P_T_58> .
_:Ndd59d119b4cb47dc95c01ce84efd64c1 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9381980> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:Ne391843f2f0048109781ea2a1b20ea9c <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_HNRNPK_Increases_r_HGNC_MYC> .
<http://www.openbel.org/bel/bp_GO_response_to_heat> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"response to heat\")" .
<http://www.openbel.org/bel/p_HGNC_MAPK14> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MAPK14)" .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:CTNNB1))" .
_:Ne53720177d19481684179086b66d1826 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N06a1bd32a94f4ce2a1c46e7dbb0432ec <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family_Increases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:\"okadaic acid\")" .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40_DirectlyDecreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyDecreases> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Decreases_tscript_p_HGNC_MNT> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) decreases tscript(p(HGNC:MNT))" .
_:Ne544f6d3246c4c0dab86782d56fad5e8 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_ATF2_pmod_P_T_51> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_ROCK1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//ROCK1> .
<http://www.openbel.org/bel/bp_GO_response_to_heat_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"response to heat\") decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N1db0146e2ed34be1a5e5b9734bd3e990 .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_growth> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_CDKN1A> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CDKN1A)" .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:SKP2),p(HGNC:MYC)) increases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family_Decreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Nc0c83a8b4060423fa6b4be26e87ef4ac .
_:N991a55aa89994d4ea481e3a143feb4e4 <http://www.openbel.org/vocabulary/hasEvidenceText> "Linoleic acid stimulated expression of c-myc mRNA. Maximum increases in c-myc (3 fold) mRNA levels occurred at 1hr of Linoleic acid treatment. The expression was found to be persistent for at least 4hr, although at lower levels than those at 1hr." .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/complex_NCH_TORC1_Complex> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//TORC1%20Complex> .
_:Nc63dbab7e50b4d019376214a8b01e545 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:N5bd7cc23bf19422d83fa2bae40a7113d <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14757441> .
_:N7651448d35c24662bac81822b11eba87 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15172994> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_p_HGNC_ZBTB17> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:ZBTB17))" .
_:N44f8154ac7d04538b58a853d2bba45f8 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Decreases_tscript_p_HGNC_MNT> .
<http://www.openbel.org/bel/p_HGNC_MAPK3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_CHEBI_troglitazone> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:troglitazone)" .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_tscript_p_HGNC_MYC_pmod_P> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:EGFR)) increases tscript(p(HGNC:MYC,pmod(P)))" .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch_Increases_tscript_p_RGD_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_RGD_Myc> .
_:N504fd9010a0a4f448ce9a271465d15fe <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18701488> .
<http://www.openbel.org/bel/complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/tscript_p_HGNC_NFYC> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_MGI_Jup> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N9f3f10819d86471ba2ffa7dc41a7d82b <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N76ac5b7fd6d944918e7df5fcb23ce536 <http://www.openbel.org/vocabulary/hasEvidenceText> "Small inhibitory RNA-induced silencing of GSK3beta prevents phosphorylation of MYC on T58, thereby inhibiting recognition of MYC by the E3 ubiquitin ligase component FBW7. Attenuating the GSK3beta-FBW7 axis results in stabilization of MYC" .
_:N1e07c28a80644063b64f6213446312f3 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11781825> .
_:Nf5e8af358b43401584456575f9257671 <http://www.openbel.org/vocabulary/hasEvidenceText> "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway." .
_:Nb8db20c1ba3a474bb9a946c630e11ad7 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MXD1_Decreases_complex_p_HGNC_MYC_p_HGNC_MAX> .
<http://www.openbel.org/bel/p_PFM_Foxo_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N9eec22bf1a854532974c8f337a008a1e .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:Nff338c2d1dbc471da136c58c35011d22 <http://www.openbel.org/vocabulary/hasEvidenceText> "Overexpression of OMgp alters PDGF signaling in fibroblasts which results in a block of mitogenic signaling. PDGF induced activation of c-Src is blocked, as is the induction of c-Myc and c-Fos, while tyrosine phosphorylation of the PDGFbeta receptor, PLCgamma1 and induction of c-Jun are intact." .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra_Increases_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(PFH:\"RAF Family\"))" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14_Increases_tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK14)) increases tscript(complex(p(HGNC:MYC),p(HGNC:MAX)))" .
_:N76ac5b7fd6d944918e7df5fcb23ce536 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16210249> .
<http://www.openbel.org/bel/p_RGD_Pax4> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Pax4> .
<http://www.openbel.org/bel/p_RGD_Pax4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N988ed9057f6143b9b4c5764238499138 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nf7374451a7004cabb76a06f13c45aefd <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_CHEBI_cisplatin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_SCHEM_Calcium_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/p_MGI_Jup_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P,S,373)) directlyDecreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Ncd371260ae5c453798f358a0c6a3da8e .
_:N90ae420ed2af403a80cc85d60a763c84 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_CCND2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Nb7b63b8575cc4bf29e72d1414150e53a <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16543245> .
_:Nf133596cb14b48c89315c64bb004bc00 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18046334> .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex_DirectlyIncreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_troglitazone_Increases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_EGID_5424> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_MGI_Pdgfb> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Pdgfb> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyDecreases> .
_:N92c663f74d154e1e8399f14d1c119ade <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> .
_:N8b93def31af64fc381e5e80a614a4f52 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:19018094> .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_Decreases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:GSK3B)) decreases p(HGNC:MYC)" .
_:N65156ac8ae414741865c2e3745d2ec28 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> .
<http://www.openbel.org/bel/kin_p_EGID_2475> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:\"Enzastaurin Hydrochloride\")" .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nc68955fa98934da0aa220541b5f9336d .
<http://www.openbel.org/bel/p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:Nbe89666de6be4021aec3ccbe0c24ea1f <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N9eec22bf1a854532974c8f337a008a1e <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9569019> .
_:N7a1c8b294ce14549bd691dbf021859e1 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12199786> .
_:N8b93def31af64fc381e5e80a614a4f52 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1_Decreases_p_HGNC_MYC> .
_:Nb8db20c1ba3a474bb9a946c630e11ad7 <http://www.openbel.org/vocabulary/hasEvidenceText> "A few studies evaluating mixed or NOS DCIS found a 100% incidence of MYC protein expression by IHC,and an 11% rate of myc amplification MYC proteins form heterodimeric complexes with basic helix-loop-helix-leucine zipper transcription factors whose activity is regulated by a number of positive (MAX) and negative (MAD, MXI1) regulators." .
<http://www.openbel.org/bel/tscript_p_MGI_Myc_Increases_bp_GO_cell_cycle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_TNFRSF10A> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/cat_p_HGNC_TNFRSF10A> .
<http://www.openbel.org/bel/p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N43bca9610845459aa0fc35e6b5e6585e .
_:N61c5f80ad33541dc86cde49e3032f7cb <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16107734> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_HOXB13_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_HOXB13> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_DirectlyIncreases_p_HGNC_MYC_pmod_P_T_58> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_58> .
<http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N06a1bd32a94f4ce2a1c46e7dbb0432ec .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_DNA_replication> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Nec20c03a78ba4826942fb08ea85c9bca <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_SCHEM_Estrogens_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:N96fe3997fdf84001b5bfdc20f6be2949 <http://www.openbel.org/vocabulary/hasEvidenceText> "hus, upon suppression of let-7c, c-myc mRNA and protein are elevated resulting in enhanced hepatocellular proliferation." .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nd926613b585a4c58a579e66ac535037f .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
_:N9d5da96e083e4321b246f785ec11de5b <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11252954> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_TNFRSF10A> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N192e8a2947d64c3faae01fe81fb1d02d .
<http://www.openbel.org/bel/p_HGNC_MXD1_Decreases_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MXD1) decreases complex(p(HGNC:MYC),p(HGNC:MAX))" .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N404334d1c59844e187533083267e7bd3 .
_:N1aaa6a8b46dc4c76a4532df7178d2d43 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16087782> .
_:N1be098f802b84302aa9d55284ed8a034 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_HBP1_Decreases_r_HGNC_MYC> .
_:N8953b0211ed04ba99f87050207458cc5 <http://www.openbel.org/vocabulary/hasEvidenceText> "Since both mTOR and PLD can stimulate Myc expression (107, 141), it is possible that the PLD-generated survival signals are mediated in part by stimulating Myc expression, which like PLD, can cooperate with signaling oncogenes to transform primary cells (71, 96, 124, 126). Estrogen also stimulates Myc expression in the estrogen receptor-positive MCF-7 breast cancer cell line (142), and the induction of Myc by estrogen has been proposed to contribute to the mitogenic effects of estrogen in breast epithelia and in breast cancer progression" .
<http://www.openbel.org/bel/kin_p_EGID_2475> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_PFH_IFNA_Family_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N3e72966e42fb40c9bce9ea1f52aeb875 .
<http://www.openbel.org/bel/p_MGI_Pim1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:N6ae3fe5c170b41b0a170612fef2c450e <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_MGI_Tgfb1> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Tgfb1)" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_DNA_replication> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases bp(GO:\"DNA replication\")" .
<http://www.openbel.org/bel/p_MGI_Tgfb1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Ne8fa4e913ac84cd99607fd5d14d402c8 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> .
_:N90ae420ed2af403a80cc85d60a763c84 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18662538> .
_:N4f9ed8d0384e4c9ab74ffa05dc267cbf <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_GSK3B_Decreases_p_HGNC_MYC> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride> .
<http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasEvidence> _:N0ecb500ea2e544b7945f14233e6d2bce .
_:N991a55aa89994d4ea481e3a143feb4e4 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:7635978> .
<http://www.openbel.org/bel/p_HGNC_CDK4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_HOXB13_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(PFM:\"Akt Family\"))" .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:Nc68955fa98934da0aa220541b5f9336d <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9305863> .
<http://www.openbel.org/bel/p_HGNC_ROCK1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:ROCK1)" .
_:Nb65b6a9148874c2cb5c45f7480c88c84 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_PFH_RAF_Family_Increases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_EGID_5424_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:Nd926613b585a4c58a579e66ac535037f <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15071503> .
<http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_MGI_Myc> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_glycolysis> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases bp(GO:glycolysis)" .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_RGD_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:\"linoleic acid\") increases r(RGD:Myc)" .
_:N6d1fd7c61a6f4dcd9a11bc84226ce633 <http://www.openbel.org/vocabulary/hasEvidenceText> "Incubation of Caco2 cells in hypoxia increased the phosphorylation of c-Myc, and this was blocked when both PI3K and ROCK were specifically inhibited (Fig. 4D). " .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family_Decreases_tscript_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(PFM:\"Foxo Family\")) decreases tscript(p(MGI:Myc))" .
<http://www.openbel.org/bel/a_CHEBI_quercetin_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_SCHEM_Calcium_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nef31cf3d9a0d41a49de1121ddaccfcf6 .
_:Nba03aff50afb4047b147ec17f756e646 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_cisplatin_Decreases_r_HGNC_MYC> .
_:N0f53ae1d18d84ffc9fcfd74e12537b12 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_CDK4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_ZBTB17> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_ZBTB17> .
<http://www.openbel.org/bel/cat_p_HGNC_SKP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:RBX1),p(HGNC:SKP2))" .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:\"D-Glucose, anhydrous\") increases p(HGNC:MYC)" .
_:Ncb5569ab91104d02901ba059e4150c2d <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10508165> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_ribosome_biogenesis> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_ribosome_biogenesis> .
<http://www.openbel.org/bel/p_PFH_RAF_Family> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//RAF%20Family> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_ATF2_pmod_P_T_51> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_ATF2_pmod_P_T_51> .
_:N44f8154ac7d04538b58a853d2bba45f8 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14749372> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex> .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/p_HGNC_RBX1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//RBX1> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//linoleic%20acid> .
_:N589e51e4d3874940a9bcb19e3ecb3510 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18495523> .
<http://www.openbel.org/bel/p_PFH_IFNA_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MYC> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//lovastatin> .
_:Ndab32b1d8d7f46aa88429464f43c2441 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/bp_GO_response_to_heat_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_CDK3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_growth> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_cell_growth> .
<http://www.openbel.org/bel/a_CHEBI_ceramide> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
_:Nab5656c22f054e01bfdce740e2cfacc4 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_ATF2_pmod_P_T_51> <http://www.openbel.org/vocabulary/hasModificationPosition> "51"^^<http://www.w3.org/2001/XMLSchema#integer> .
_:N68658d4f610c43e987847c3e04627376 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16543245> .
<http://www.openbel.org/bel/a_SCHEM_Estrogens_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_MGI_Pim1_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_MGI_Myc> .
<http://www.openbel.org/bel/p_RGD_Pax4> <http://www.w3.org/2000/01/rdf-schema#label> "p(RGD:Pax4)" .
<http://www.openbel.org/bel/p_HGNC_MNT> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(EGID:2475)) increases p(HGNC:MYC)" .
<http://www.openbel.org/bel/p_PFH_IFNA_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Nd91b2ea4b1664798b1ba52a351679a82 <http://www.openbel.org/vocabulary/hasEvidenceText> "HIF1 also directly induces MXI1 (FIG. 1), which competes for and binds MAX, thereby antagonizing MYC function25,46." .
_:N8dd9acc9a4ab4d18be18d81932c22166 <http://www.openbel.org/vocabulary/hasEvidenceText> "Modified assertion" .
<http://www.openbel.org/bel/p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Myc)" .
<http://www.openbel.org/bel/a_CHEBI_simvastatin> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//simvastatin> .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_PFH_RAF_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nbe89666de6be4021aec3ccbe0c24ea1f <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> .
_:Na98752b5db4e47bf9bab6d2e9149f448 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> .
_:Nd3730d8191f2468fbbf54c05eb80e43a <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_CDK3> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CDK3)" .
_:N00a98f5d04cd47d5bda1c6a9eeb72d6c <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12149649> .
<http://www.openbel.org/bel/r_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nba42f14b886b47ce9309e4fb31728883 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MAX> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N6ae3fe5c170b41b0a170612fef2c450e <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15976005> .
_:N1562ff788316497a9c6f77a7c3d0b751 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N6430555704484377b345277534b7b930 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MAPK14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_MGI_Jup_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_MGI_Jup> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ModifiedProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ModifiedProteinAbundance> .
_:Nba42f14b886b47ce9309e4fb31728883 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_glycolysis> .
<http://www.openbel.org/bel/complex_NCR_Nfkb_Complex> <http://www.w3.org/2000/01/rdf-schema#label> "complex(NCR:\"Nfkb Complex\")" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_DNA_replication> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_DNA_replication> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N07400840bde944cd8f2639a0f0b26987 .
<http://www.openbel.org/bel/p_HGNC_CCND2> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CCND2> .
_:Nbfa807e779c245489c621cd74e5b68e5 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11297548> .
<http://www.openbel.org/bel/a_SCHEM_Calcium> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CUL1> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_RB1_pmod_P_S_780> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Ndd6d70c4f9ef42348214e7e33692b781 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC_Increases_p_HGNC_CDKN1A> .
_:Nba42f14b886b47ce9309e4fb31728883 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15199147> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_SRC> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress> <http://www.w3.org/2000/01/rdf-schema#label> "path(SDIS:\"laminar shear stress\")" .
_:N9ad974896fae4850ad39640dbce741e3 <http://www.openbel.org/vocabulary/hasEvidenceText> "Furthermore, when HL-60 myeloid leukemic cells were differentiated with phorbol ester (TPA), PBK/TOPK protein expression was strongly down-regulated by 24 h. Under these same conditions, phosphorylated c-Myc was rapidly down-regulated (by 4 h), while the levels of cyclin D1 and phosphorylated p38 were constant." .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nd5c3bcf7668747169a3fa949c103cf90 .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_EGID_5243> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N4e1ccbf0fc994101a992ceb90cf432c0 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_CHEBI_ceramide> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:ceramide)" .
<http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Nbe89666de6be4021aec3ccbe0c24ea1f .
<http://www.openbel.org/bel/bp_GO_glycolysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_KITLG> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases cat(p(HGNC:KITLG))" .
<http://www.openbel.org/bel/complex_NCH_TORC1_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/p_MGI_Pdgfb> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Pdgfb)" .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CDK3> .
<http://www.openbel.org/bel/p_HGNC_MNT> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MNT)" .
_:N9d5da96e083e4321b246f785ec11de5b <http://www.openbel.org/vocabulary/hasEvidenceText> "Figure 1 | The ErbB signalling network." .
<http://www.openbel.org/bel/p_HGNC_MAPK1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_CDKN2A> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CDKN2A)" .
<http://www.openbel.org/bel/bp_GO_cell_cycle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
_:N8d1ddfc4ebc34fa78cd22c6920f29de5 <http://www.openbel.org/vocabulary/hasEvidenceText> "Incubation of Caco2 cells in hypoxia increased the phosphorylation of c-Myc, and this was blocked when both PI3K and ROCK were specifically inhibited (Fig. 4D). " .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Nc0c83a8b4060423fa6b4be26e87ef4ac <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N968a8cf024674412968475a30839b9fc <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_HOXB13_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CTCF> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_SNIP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nb65b6a9148874c2cb5c45f7480c88c84 <http://www.openbel.org/vocabulary/hasEvidenceText> ", MEK1 and MEK2 are the only known substrates for B-Raf.154-157 A consistent theme in studies on MEK/ERK activation by Raf is that B-Raf is far more potent at activating downstream kinases than either A-Raf or C-Raf. Several lines of evidence also indicate that B-Raf has a much higher affinity for its substrate than the other Raf isoforms and is 50-fold more potent at phosphorylating MEK1 and MEK2 than either A-Raf or C-Raf.125,158 The respective downstream substrates of MEK1 and MEK2 are ERK1 (p44MAPK) and ERK2 (p42MAPK), which are translocated to the nucleus where they ultimately induce an array of cytoplasmic and nuclear regulatory proteins.50,159-162 Effectors include the nuclear transcription factors Elk-1, Fos, Jun, AP-1, and Myc, which regulate genes encoding proteins that play key roles in proliferation, angiogenesis, metastasis, and resistance to anticancer therapeutics.51" .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4_Increases_r_RGD_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(RGD:Pax4)) increases r(RGD:Myc)" .
_:N00a98f5d04cd47d5bda1c6a9eeb72d6c <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_MGI_Myc> .
<http://www.openbel.org/bel/p_PFH_RAF_Family> <http://www.w3.org/2000/01/rdf-schema#label> "p(PFH:\"RAF Family\")" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P,S,62)) directlyIncreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/tscript_p_HGNC_NFYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:NFYC))" .
_:Ncd371260ae5c453798f358a0c6a3da8e <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> .
_:Ne8fa4e913ac84cd99607fd5d14d402c8 <http://www.openbel.org/vocabulary/hasEvidenceText> "Phosphorylation by Pak2 inhibits the ability of Myc to activate transcription" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK3))" .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:CSNK2A1))" .
<http://www.openbel.org/bel/p_HGNC_ROCK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_CHEBI_progesterone> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:progesterone)" .
<http://www.openbel.org/bel/p_HGNC_RPL11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_PFH_IFNA_Family_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) decreases complex(p(HGNC:CDKN1B),p(HGNC:CDK2),p(HGNC:CCNB1))" .
<http://www.openbel.org/bel/p_HGNC_CSNK2A1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CSNK2A1)" .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:\"Tetradecanoylphorbol acetate\")" .
<http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_ROCK2> .
_:Nc0c83a8b4060423fa6b4be26e87ef4ac <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family_Decreases_tscript_p_MGI_Myc> .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:N589e51e4d3874940a9bcb19e3ecb3510 <http://www.openbel.org/vocabulary/hasEvidenceText> "Exposure of SCLC or PNECs to NNK or nicotine increased expression of the a7nAChR and caused influx of Ca2+, activation of PKC, Raf-1, ERK1/2, and c-myc, resulting in the stimulation of cell proliferation." .
<http://www.openbel.org/bel/kin_p_EGID_5424> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(EGID:5424))" .
<http://www.openbel.org/bel/p_HGNC_CDK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Myc) increases bp(GO:\"cell proliferation\")" .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_PFH_PRKC_Family> .
<http://www.openbel.org/bel/complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:MNT),p(HGNC:MAX))" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P,S,373))" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Tetradecanoylphorbol%20acetate> .
_:Nc63dbab7e50b4d019376214a8b01e545 <http://www.openbel.org/vocabulary/hasEvidenceText> "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways." .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_CDKN2A> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:N1db0146e2ed34be1a5e5b9734bd3e990 <http://www.openbel.org/vocabulary/hasEvidenceText> "Figure 2 in the actual paper." .
<http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_MGI_Myc> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N1e07c28a80644063b64f6213446312f3 <http://www.openbel.org/vocabulary/hasEvidenceText> "In this work we present evidence that v-Myc encoded by the avian retrovirus MC29 stimulates activating transcription factor 2 (ATF2)-dependent transcription. Analysis of the effect of Myc on ATF2 shows that v-Myc prolongs the half-life of ATF2 and induces the phosphorylation of N-terminal sites of ATF2 (Thr-69 and Thr-71) which have previously been identified as the target sites of stress-activated protein kinases and implicated in the regulation of ATF2 activity." .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:\"linoleic acid\") increases r(HGNC:MYC)" .
<http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ndd710746cfbd4e6bbc1dc8bc7835ec34 .
_:Nf5e8af358b43401584456575f9257671 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16729045> .
_:Ndab32b1d8d7f46aa88429464f43c2441 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family_Decreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/p_HGNC_MXD1_Decreases_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasEvidence> _:Nb8db20c1ba3a474bb9a946c630e11ad7 .
_:Nba03aff50afb4047b147ec17f756e646 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15940259> .
<http://www.openbel.org/bel/p_PFH_IFNA_Family_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:Nb7dbd5320a3d405eabcb34d4ed955d8a <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_ceramide_Decreases_p_HGNC_MYC> .
_:Nd3730d8191f2468fbbf54c05eb80e43a <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12769844> .
<http://www.openbel.org/bel/kin_p_EGID_5424_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC_DirectlyDecreases_tscript_p_HGNC_ZBTB17> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:ZBTB17),p(HGNC:MYC)) directlyDecreases tscript(p(HGNC:ZBTB17))" .
<http://www.openbel.org/bel/a_CHEBI_cisplatin_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nba03aff50afb4047b147ec17f756e646 .
<http://www.openbel.org/bel/bp_GO_cell_cycle> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"cell cycle\")" .
<http://www.openbel.org/bel/p_HGNC_MXI1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MXI1> .
<http://www.openbel.org/bel/p_HGNC_SRC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:SRC)" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_MTA1> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nd3730d8191f2468fbbf54c05eb80e43a .
_:Nf75048be6fa64a108a04ad5ab0849a41 <http://www.openbel.org/vocabulary/hasEvidenceText> "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase.  Data taken from table 2.  Fold change >= or <= 2.0, P < 0.05.  181 genes" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358> <http://www.openbel.org/vocabulary/hasModificationPosition> "358"^^<http://www.w3.org/2001/XMLSchema#integer> .
_:Nbdedc3d6738a410a8fdc1e79532c9008 <http://www.openbel.org/vocabulary/hasEvidenceText> "Stable elevated expression of PLD2 also increased Myc expression and provided a Myc-dependent survival signal in the absence of E2." .
<http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N5a83ea4cdbf34824bc775f1392e7d380 .
<http://www.openbel.org/bel/p_HGNC_ATF2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:ATF2)" .
_:N6f6b239300ec4eaebf127678482c805f <http://www.openbel.org/vocabulary/hasEvidenceText> "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway \u2014 for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-D\u2013Cdk4 from phosphorylating Rb \u2014 unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 4\u20136,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B." .
_:N6ae3fe5c170b41b0a170612fef2c450e <http://www.openbel.org/vocabulary/hasEvidenceText> "Supplemental Table 1 - genes regulated by progesterone at 48h up genes" .
_:N6df102a43ca3429abb919162b7cd1be0 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14973112> .
_:N6d1fd7c61a6f4dcd9a11bc84226ce633 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> .
_:N6a8bc81eb3444139a60f4aa73b284a8f <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10679091> .
<http://www.openbel.org/bel/p_MGI_Pim1_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_MGI_Pim1> .
<http://www.openbel.org/bel/p_HGNC_BCL2L11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MLXIPL> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
_:N7966c306f2c64214871a677eed78476b <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_CTCF_DirectlyDecreases_r_HGNC_MYC> .
_:N61c5f80ad33541dc86cde49e3032f7cb <http://www.openbel.org/vocabulary/hasEvidenceText> "The Myc-dependent survival signal generated by E2 was dependent upon basal levels of mTOR (mammalian target of rapamycin) and two upstream regulators of mTOR, phosphatidylinositol 3-kinase and phospholipase D (PLD)." .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N6a8bc81eb3444139a60f4aa73b284a8f .
<http://www.openbel.org/bel/a_CHEBI_nicotine_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Nba03aff50afb4047b147ec17f756e646 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MTA1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_BCL2L11> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//BCL2L11> .
<http://www.openbel.org/bel/p_HGNC_ATF2_pmod_P_T_51> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_MGI_Pim1_Increases_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Pim1) increases p(MGI:Myc)" .
<http://www.openbel.org/bel/tscript_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(MGI:Myc))" .
<http://www.openbel.org/bel/p_RGD_Myc> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Myc> .
<http://www.openbel.org/bel/r_MGI_Myc> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Myc> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_tscript_p_HGNC_ATF2> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases tscript(p(HGNC:ATF2))" .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_EGID_5243> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:N0f10fce3502e4fffbc40529f64a83f52 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family_Decreases_tscript_p_HGNC_MYC> .
_:Ne3380953214047c1a84a91527144916f <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14749374> .
_:Nbfa807e779c245489c621cd74e5b68e5 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_pmod_P> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_NCH_Nfkb_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
_:Nc6803fc006034e12bc5bf37b359855c6 <http://www.openbel.org/vocabulary/hasEvidenceText> "Overexpression of OMgp alters PDGF signaling in fibroblasts which results in a block of mitogenic signaling. PDGF induced activation of c-Src is blocked, as is the induction of c-Myc and c-Fos, while tyrosine phosphorylation of the PDGFbeta receptor, PLCgamma1 and induction of c-Jun are intact." .
_:N6df102a43ca3429abb919162b7cd1be0 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nef31cf3d9a0d41a49de1121ddaccfcf6 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Calcium_Increases_r_HGNC_MYC> .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N26a979e9013545c7ae735eb91da0b474 .
_:Ne8641cf88e324e7eb371d0856d24ada2 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11252954> .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_PFH_RAF_Family> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF_DirectlyDecreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N40f19a5d5afe4e90bf57b776da642e32 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_SKP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_okadaic_acid> .
<http://www.openbel.org/bel/a_CHEBI_nicotine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N9eec22bf1a854532974c8f337a008a1e <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_ATF2> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//ATF2> .
<http://www.openbel.org/bel/p_HGNC_CTNNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasEvidence> _:N8d1ddfc4ebc34fa78cd22c6920f29de5 .
_:N6f7d84eee3ae4a539598fb6c5868f4e1 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:17597761> .
_:Nef31cf3d9a0d41a49de1121ddaccfcf6 <http://www.openbel.org/vocabulary/hasEvidenceText> "High glucose and high calcium also up-regulated the expression of c-Myc, but only the high glucose group showed significant difference from control (39% +/- 10% vs 24% +/- 8%, p < 0.05)." .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_CDKN2A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/bp_GO_response_to_heat> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//response%20to%20heat> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_linoleic_acid> .
_:Ne391843f2f0048109781ea2a1b20ea9c <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11121407> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_tscript_p_HGNC_ATF2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_HOXB13_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CDK2> .
_:N940f4d10508044188ff15ee88bacd91a <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15489884> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:Nd84b73e335c649f18bf475105af33b03 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15970569> .
_:N96892952b7fe40afaa317426816bc84f <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18701488> .
<http://www.openbel.org/bel/p_HGNC_CCNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_KITLG> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//KITLG> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Pathology> .
<http://www.openbel.org/bel/p_HGNC_ATF2_pmod_P_T_51> <http://www.openbel.org/vocabulary/hasModificationType> <http://www.openbel.org/vocabulary/PhosphorylationThreonine> .
_:Nef31cf3d9a0d41a49de1121ddaccfcf6 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N26a979e9013545c7ae735eb91da0b474 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex_Increases_p_HGNC_MYC> .
<http://www.openbel.org/bel/bp_GO_ribosome_biogenesis> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"ribosome biogenesis\")" .
<http://www.openbel.org/bel/tscript_p_HGNC_NFYC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_NFYC> .
<http://www.openbel.org/bel/p_HGNC_PAK2> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//PAK2> .
<http://www.openbel.org/bel/kin_p_MGI_Stk11> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_MGI_Stk11> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
_:N7c1828b18f1a48ad9129432b7d669dc6 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_EGID_5424_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/a_SCHEM_Calcium> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:Calcium)" .
<http://www.openbel.org/bel/r_HGNC_PLD2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/RNAAbundance> .
<http://www.openbel.org/bel/cat_p_HGNC_KITLG> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_KITLG> .
<http://www.openbel.org/bel/p_MGI_Pim1_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_EGID_5424> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/bp_MESHPP_Apoptosis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/complex_p_HGNC_MYC_p_HGNC_MAX> .
<http://www.openbel.org/bel/p_HGNC_SKP2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:SKP2)" .
<http://www.openbel.org/bel/p_HGNC_CCNB1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CCNB1> .
_:Nfe6b9fc05c38404a9768fcef6fe603d0 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_MTA1> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:Nbd03c7b0b958436b9acda3c1053fe3f7 <http://www.openbel.org/vocabulary/hasEvidenceText> "In keratinocytes and mammary epithelial cells, c-MYC downregulation is mediated by a TGF?-induced protein complex containing Smad3/4, p107, E2F4/5, and C/EBP? (Chen et al., 2002; Gomis et al., 2006b)." .
_:N7b572f44c26e4d0e98024c63906bbd2b <http://www.openbel.org/vocabulary/hasEvidenceText> "We report that TNF induces DNA replication in growth-arrested LE6 cells and that its effect involves the activation of NFkappaB and STAT3 and an increase in c-myc and IL-6 mRNAs. We conclude that NFkappaB is an essential component of the TNF proliferative pathway and that TNF-induced changes in IL-6 mRNA, STAT3, and c-myc mRNA are dependent on NFkappaB activation." .
<http://www.openbel.org/bel/p_HGNC_CDKN2A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/a_CHEBI_cisplatin_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_cisplatin> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:CDK3)) increases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N5bd7cc23bf19422d83fa2bae40a7113d .
_:N7cab6257d5a04b9b8215f4cd55e5c098 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11282029> .
<http://www.openbel.org/bel/a_CHEBI_mifepristone_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CCND2> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_ATF2_pmod_P_T_51> <http://www.openbel.org/vocabulary/hasEvidence> _:N1e07c28a80644063b64f6213446312f3 .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_MGI_Myc> .
_:Ne53720177d19481684179086b66d1826 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358_DirectlyDecreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_MGI_Myc> .
_:N940f4d10508044188ff15ee88bacd91a <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
_:Ncb5569ab91104d02901ba059e4150c2d <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> .
<http://www.openbel.org/bel/bp_GO_DNA_replication> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//DNA%20replication> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF_DirectlyDecreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N7966c306f2c64214871a677eed78476b .
<http://www.openbel.org/bel/a_CHEBI_calcitriol_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:calcitriol) decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/a_SCHEM_Estrogens_Increases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:Estrogens) increases r(HGNC:MYC)" .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1_Decreases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:CTNNB1)) decreases p(HGNC:MYC)" .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:HIF1A)) decreases tscript(p(HGNC:MYC))" .
_:N940f4d10508044188ff15ee88bacd91a <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N1aaa6a8b46dc4c76a4532df7178d2d43 <http://www.openbel.org/vocabulary/hasEvidenceText> "Cyclic stretch also significantly increased DNA-protein binding activity of Myc-Max." .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/a_CHEBI_progesterone> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//progesterone> .
<http://www.openbel.org/bel/p_HGNC_ATF2_pmod_P_T_51> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_ATF2> .
_:N65156ac8ae414741865c2e3745d2ec28 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15358814> .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//okadaic%20acid> .
<http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
_:Ndd59d119b4cb47dc95c01ce84efd64c1 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_quercetin_Decreases_r_HGNC_MYC> .
_:N30a68934867f4b448b158b94f339afd7 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15723053> .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CCNB1> .
<http://www.openbel.org/bel/r_RGD_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "r(RGD:Myc)" .
_:N6a8bc81eb3444139a60f4aa73b284a8f <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N5415688460f243b2a95ffe04963f4de6 .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_58> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ModifiedProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_HOXB13_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:HOXB13) decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/kin_p_EGID_2475> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family> .
<http://www.openbel.org/bel/p_HGNC_NFYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:NFYC)" .
_:N4e1ccbf0fc994101a992ceb90cf432c0 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:7635978> .
<http://www.openbel.org/bel/p_HGNC_SRC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nbdedc3d6738a410a8fdc1e79532c9008 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/r_HGNC_PLD2_Increases_p_HGNC_MYC> .
_:N5415688460f243b2a95ffe04963f4de6 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_RGD_Pax4_Increases_r_RGD_Myc> .
_:N404334d1c59844e187533083267e7bd3 <http://www.openbel.org/vocabulary/hasEvidenceText> "When the oxygen supply is depleted, normal cells become hypoxic, which results in the expression of HIFs and a decrease in the expression level of MYC." .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40_DirectlyDecreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40> .
<http://www.openbel.org/bel/complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MLXIPL> .
_:Nf7374451a7004cabb76a06f13c45aefd <http://www.openbel.org/vocabulary/hasEvidenceText> "3-dimensional Matrigel culture system\u2014has shown that polarity defects accompanying LKB1 inactivation unmask the oncogenic activity of c-Myc (Partanen et al., 2007)." .
<http://www.openbel.org/bel/a_CHEBI_progesterone> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/p_MGI_Myc> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Myc> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P,S,62))" .
<http://www.openbel.org/bel/p_HGNC_CUL1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nd5c3bcf7668747169a3fa949c103cf90 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nb5563ff8e8b54adb9469097102d70b07 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(PFH:\"RAF Family\")) increases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N65156ac8ae414741865c2e3745d2ec28 .
_:Nf3d25589d44449fda7a9282f1c834cdc <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2_Increases_tscript_p_HGNC_MYC> .
_:N7b572f44c26e4d0e98024c63906bbd2b <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10616907> .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex_DirectlyIncreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:lovastatin) increases r(MGI:Myc)" .
<http://www.openbel.org/bel/p_HGNC_SRC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(PFM:\"Foxo Family\"))" .
_:N54c58219c4da4202a8f5ebfba33222bb <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_CDKN2A> .
_:N43bca9610845459aa0fc35e6b5e6585e <http://www.openbel.org/vocabulary/hasEvidenceText> "Inhibition of Myc by LIMK1 is via inhibition of Stat3 phosphorylation, because constitutively active cofilin or inhibition of Rho kinase results in Stat3 phosphorylation and increased Myc levels, whereas dominant negative Stat3 abolishes the effect. " .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:HIF1A),p(HGNC:MAX))" .
<http://www.openbel.org/bel/a_CHEBI_cisplatin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:Nb7dbd5320a3d405eabcb34d4ed955d8a <http://www.openbel.org/vocabulary/hasEvidenceText> "C2-ceramide was found to inhibit the growth of Bel7402 cells by inducing cell cycle arrest. During the process, the expression of p21 protein increased, while that of cyclinD1, phospho-ERK1/2 and c-myc decreased. Furthermore, the level of CDK7 was downregulated, while the transcriptional activity of PPARgamma was upregulated. " .
<http://www.openbel.org/bel/p_PFM_Stat5_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_troglitazone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ncd484cf247514b63b5b2570c63ed7e03 .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P_DirectlyIncreases_tscript_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Myc,pmod(P)) directlyIncreases tscript(p(MGI:Myc))" .
<http://www.openbel.org/bel/bp_GO_response_to_heat_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ndab32b1d8d7f46aa88429464f43c2441 .
<http://www.openbel.org/bel/p_HGNC_MAPK1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Nccbe5facd42a4c4986b9ffaf6125ac61 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasModificationPosition> "62"^^<http://www.w3.org/2001/XMLSchema#integer> .
_:N61c5f80ad33541dc86cde49e3032f7cb <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family_Increases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(PFH:\"PRKC Family\")) increases r(HGNC:MYC)" .
<http://www.openbel.org/bel/p_HGNC_MXI1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:EGFR))" .
_:Ndd710746cfbd4e6bbc1dc8bc7835ec34 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/path_SDIS_laminar_shear_stress> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:N247e30732bcc41bcbc2823d914feb665 <http://www.openbel.org/vocabulary/hasEvidenceText> "In this work we present evidence that v-Myc encoded by the avian retrovirus MC29 stimulates activating transcription factor 2 (ATF2)-dependent transcription. Analysis of the effect of Myc on ATF2 shows that v-Myc prolongs the half-life of ATF2 and induces the phosphorylation of N-terminal sites of ATF2 (Thr-69 and Thr-71) which have previously been identified as the target sites of stress-activated protein kinases and implicated in the regulation of ATF2 activity." .
_:N0ecb500ea2e544b7945f14233e6d2bce <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> .
_:N6f0f4a245ce6448ab1bdf8b7ccc505a9 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_PFM_Akt_Family_Increases_r_MGI_Myc> .
_:Nb7b63b8575cc4bf29e72d1414150e53a <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:N26a979e9013545c7ae735eb91da0b474 <http://www.openbel.org/vocabulary/hasEvidenceText> "The signalling inhibitors rapamycin and wortmannin blocked the phosphorylation of 4E-BP1 and abolished the translational component of the c-myc response. " .
<http://www.openbel.org/bel/p_HGNC_SNIP1_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//D-Glucose,%20anhydrous> .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_MGI_Il4> .
<http://www.openbel.org/bel/complex_NCH_Nfkb_Complex> <http://www.w3.org/2000/01/rdf-schema#label> "complex(NCH:\"Nfkb Complex\")" .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N76ac5b7fd6d944918e7df5fcb23ce536 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_RB1_pmod_P_S_780> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
_:N7c1828b18f1a48ad9129432b7d669dc6 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_p_HGNC_MYC_pmod_P> .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_HBP1> .
_:N648dc396fdc24ea2a04b2d595f383f8f <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_EGID_5243> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_RB1_pmod_P_S_780> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases p(HGNC:RB1,pmod(P,S,780))" .
_:N40e0a75abd734a27b75f90db3110fb63 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nd3730d8191f2468fbbf54c05eb80e43a <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> .
_:Nfa1009b83fa74bdfa8c1a4853a5f3c98 <http://www.openbel.org/vocabulary/hasEvidenceText> "Inhibition of either KPC1 or KPC2 by RNA interference or with dominant-negative mutants delays p27 degradation at the G0 G1 transition . These results indicate that the degradation of p27 is regulated by two distinct mechanisms: translocation-coupled cytoplasmic ubiquitylation by KPC at the G0 G1 transition and nuclear ubiquitylation by SKP2 during S and G2 phases (see Supplementary information S2 (figure)). Given that, in a subset of breast cancers (32 out of 84 samples)45, p27 levels were low despite SKP2 not being expressed, it remains possible that the expression of KPC might be elevated in such cases. Surprisingly, SKP2 also binds to MYC through its MB2 and helix loop helix leucine zipper (HLHZip) domains, and thereby mediates its ubiquitylation and degradation. However, SKP2 unexpectedly increases the transactivation activity of MYC, indicating that SKP2 is a transcriptional cofactor. Consistent with this notion, MYC accumulates, but its transcriptional activity is reduced, in mouse Skp2 ko cells." .
<http://www.openbel.org/bel/tscript_p_HGNC_ATF2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N8dd9acc9a4ab4d18be18d81932c22166 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10970882> .
<http://www.openbel.org/bel/p_HGNC_KITLG> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_RB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N6f6b239300ec4eaebf127678482c805f <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_BCL2L11> .
<http://www.openbel.org/bel/p_HGNC_MXD1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MXD1> .
<http://www.openbel.org/bel/p_HGNC_MXD1_Decreases_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MXD1> .
<http://www.openbel.org/bel/p_MGI_Jup_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_MGI_Myc> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_MTA1> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MTA1> .
<http://www.openbel.org/bel/p_EGID_2475> <http://www.w3.org/2000/01/rdf-schema#label> "p(EGID:2475)" .
_:Nd5c3bcf7668747169a3fa949c103cf90 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:19966300> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:ZBTB17),p(HGNC:MYC))" .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/tscript_p_HGNC_MNT> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MNT))" .
_:Nab5656c22f054e01bfdce740e2cfacc4 <http://www.openbel.org/vocabulary/hasEvidenceText> "The c-Myc oncoprotein induces cell proliferation" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14_Increases_tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_EGID_2475> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//2475> .
<http://www.openbel.org/bel/p_PFM_Stat5_Family> <http://www.w3.org/2000/01/rdf-schema#label> "p(PFM:\"Stat5 Family\")" .
_:Nb5563ff8e8b54adb9469097102d70b07 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_growth> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_BCL2L11> <http://www.openbel.org/vocabulary/hasEvidence> _:N6f6b239300ec4eaebf127678482c805f .
<http://www.openbel.org/bel/r_HGNC_PLD2_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/r_HGNC_PLD2> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_SKP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Ncd371260ae5c453798f358a0c6a3da8e <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10679091> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_S_780> <http://www.openbel.org/vocabulary/hasModificationPosition> "780"^^<http://www.w3.org/2001/XMLSchema#integer> .
_:Ne8641cf88e324e7eb371d0856d24ada2 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_S_780> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_BHLHE40> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//BHLHE40> .
_:N80f1328034b84745a8d8c7bdb891842e <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Jup_Decreases_p_MGI_Myc> .
<http://www.openbel.org/bel/a_CHEBI_calcitriol_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N40f19a5d5afe4e90bf57b776da642e32 <http://www.openbel.org/vocabulary/hasEvidenceText> "Here we report that in quiescent cells the Odc E-boxes are occupied by Max and Mnt, a putative Myc antagonist, and that this complex is displaced by Myc-Max complexes in proliferating cells." .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nce4ece696d424c3cbb74627e43ce56fa .
_:Ne67695a0f36e49b78e704d67e2f6ccd4 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:1315324> .
_:Ndab32b1d8d7f46aa88429464f43c2441 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14978005> .
_:N2964e0175fd0472bb9b07b985d46c280 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N06a1bd32a94f4ce2a1c46e7dbb0432ec <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> .
<http://www.openbel.org/bel/p_HGNC_CTCF> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> <http://www.openbel.org/vocabulary/hasEvidence> _:Ncb5569ab91104d02901ba059e4150c2d .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex> .
<http://www.openbel.org/bel/a_CHEBI_mifepristone_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_MGI_Stk11_Decreases_tscript_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(MGI:Stk11)) decreases tscript(p(MGI:Myc))" .
<http://www.openbel.org/bel/p_HGNC_SNIP1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//SNIP1> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_RGD_Myc> .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CDKN1B> .
<http://www.openbel.org/bel/p_HGNC_ATF2_pmod_P_T_51> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ModifiedProteinAbundance> .
<http://www.openbel.org/bel/r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/RNAAbundance> .
<http://www.openbel.org/bel/p_HGNC_EGFR> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//EGFR> .
_:N96892952b7fe40afaa317426816bc84f <http://www.openbel.org/vocabulary/hasEvidenceText> "Table S2. Other responsive genes are deregulated by enzastaurin in U251, as detected by Anova and Ingenuity Pathway Analysis software, shown in Tables S2 and S3 respectively. U251 cells were treated in triplicates with 10?M enzastaurin for 18 hours. The initial gene expression analysis data files (CEL files) were generated using Affymetrix GeneChip Operating Software (GCOS) version 1.2. CEL files were processed as described earlier (11). p-value 0.001 and 1.5-fold change were applied as thresholds to select up- or down- regulated probes. " .
_:N5415688460f243b2a95ffe04963f4de6 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15596543> .
<http://www.openbel.org/bel/a_SCHEM_Estrogens_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_SCHEM_Estrogens> .
<http://www.openbel.org/bel/p_PFH_IFNA_Family_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_TNFRSF10A> <http://www.openbel.org/vocabulary/hasEvidence> _:N861eff9ccc14484cac0223d99b2c742b .
_:N690e05d73f194492ae44aa58eec8ee97 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:17341548> .
_:Nbe89666de6be4021aec3ccbe0c24ea1f <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16391002> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_KITLG> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N7a09e7bd1d464289b2e82114d3ffd01d <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Estrogens_Increases_r_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC_Increases_p_HGNC_CDKN1A> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ne8641cf88e324e7eb371d0856d24ada2 .
_:N2964e0175fd0472bb9b07b985d46c280 <http://www.openbel.org/vocabulary/hasEvidenceText> "We nowshow that p27 is rapidly and transiently sequestered by cyclin D2-Cdk4 complexesupon activation of Myc and that cyclin D2 is a direct target gene of Myc." .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_tscript_p_HGNC_ATF2> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(PFM:\"Stat5 Family\"))" .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_ATF2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_MGI_Tgfb1> .
_:N30a68934867f4b448b158b94f339afd7 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_ribosome_biogenesis> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF_DirectlyDecreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:CTCF)) directlyDecreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nf133596cb14b48c89315c64bb004bc00 .
<http://www.openbel.org/bel/p_HGNC_MXI1_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch> <http://www.w3.org/2000/01/rdf-schema#label> "path(SDIS:\"cyclic stretch\")" .
_:Nf7374451a7004cabb76a06f13c45aefd <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_MGI_Stk11_Decreases_tscript_p_MGI_Myc> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases kin(p(HGNC:CDK2))" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Decreases_tscript_p_HGNC_MNT> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:Naec820bea73a4ab68c10591102ddeeec <http://www.openbel.org/vocabulary/hasEvidenceText> "Mutational inactivation of the Myc p21 activated kinase 2 (PAK2) phosphorylation sites increased Myc activity and further enhanced epidermal differentiation. " .
_:N76753b3dfcbf442cb26076f384561ac6 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:17157259> .
_:N2cb4acffb5d64d91b5a00ee44dca98af <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_ribosome_biogenesis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_quercetin_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ndd59d119b4cb47dc95c01ce84efd64c1 .
_:N648dc396fdc24ea2a04b2d595f383f8f <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12390804> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasEvidence> _:Nec20c03a78ba4826942fb08ea85c9bca .
_:N9f3f10819d86471ba2ffa7dc41a7d82b <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9811456> .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:fulvestrant) decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasEvidence> _:N6430555704484377b345277534b7b930 .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:Sirolimus)" .
<http://www.openbel.org/bel/p_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC_Increases_p_HGNC_CDKN1A> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N7a1c8b294ce14549bd691dbf021859e1 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_calcitriol_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/p_PFH_PRKC_Family> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//PRKC%20Family> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Naec820bea73a4ab68c10591102ddeeec .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:HBP1)) decreases r(HGNC:MYC)" .
_:Ndd6d70c4f9ef42348214e7e33692b781 <http://www.openbel.org/vocabulary/hasEvidenceText> "a study using HCT116 colon carcinoma cells depleted of either p53 or p21 found that HIF1? is required for cellcycle arrest through the induction of p21 by a direct interaction between HIF1? and MYC39." .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family_Decreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_CDKN2A> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:N7b572f44c26e4d0e98024c63906bbd2b <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex_Increases_r_RGD_Myc> .
<http://www.openbel.org/bel/p_PFM_Stat5_Family> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Stat5%20Family> .
<http://www.openbel.org/bel/p_MGI_Pim1_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Nd4657abd7a5845c2bbbd4427c19af3aa .
_:N8dd9acc9a4ab4d18be18d81932c22166 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_EGID_5243> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//5243> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N96892952b7fe40afaa317426816bc84f .
_:N8953b0211ed04ba99f87050207458cc5 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N861eff9ccc14484cac0223d99b2c742b <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_TNFRSF10A> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:Nd84b73e335c649f18bf475105af33b03 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N8953b0211ed04ba99f87050207458cc5 .
<http://www.openbel.org/bel/kin_p_HGNC_CDK2> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:CDK2))" .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:GSK3B))" .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_RGD_Myc> .
<http://www.openbel.org/bel/a_CHEBI_troglitazone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_SNIP1_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N0ecb500ea2e544b7945f14233e6d2bce <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11839798> .
_:N6430555704484377b345277534b7b930 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> .
_:N07400840bde944cd8f2639a0f0b26987 <http://www.openbel.org/vocabulary/hasEvidenceText> "TABLE 2  Distinct alterations in gene expression induced by lovastatin, simvastatin, or pravastatin in the cerebral cortex of C57BL/6 mice" .
<http://www.openbel.org/bel/p_HGNC_MLXIPL> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MLXIPL)" .
<http://www.openbel.org/bel/a_CHEBI_lovastatin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N555ffda1fd51462eb070a86fb398a693 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9619370> .
<http://www.openbel.org/bel/p_MGI_Stk11> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Stk11> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasEvidence> _:N6d1fd7c61a6f4dcd9a11bc84226ce633 .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N1bf5cabc1ef24aef8540926d8edcb184 .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N9d5da96e083e4321b246f785ec11de5b .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_tscript_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasEvidence> _:Nbfa807e779c245489c621cd74e5b68e5 .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_GSK3B> .
<http://www.openbel.org/bel/p_HGNC_SNIP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ne67695a0f36e49b78e704d67e2f6ccd4 .
<http://www.openbel.org/bel/p_EGID_5243> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_TNFRSF10A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_RBX1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_nicotine> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//nicotine> .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_MGI_Myc> .
<http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_EGID_2475> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_SRC> .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N7cab6257d5a04b9b8215f4cd55e5c098 <http://www.openbel.org/vocabulary/hasEvidenceText> "Modified assertion" .
_:N5bd7cc23bf19422d83fa2bae40a7113d <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate_Decreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_EGID_5424> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_EGID_5424> .
<http://www.openbel.org/bel/p_HGNC_NFYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CTNNB1> .
<http://www.openbel.org/bel/bp_GO_response_to_heat> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_p_HGNC_MYC_pmod_P> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:EGFR)) increases p(HGNC:MYC,pmod(P))" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ne3380953214047c1a84a91527144916f .
<http://www.openbel.org/bel/complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//laminar%20shear%20stress> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/p_HGNC_CCND2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CCND2)" .
<http://www.openbel.org/bel/p_HGNC_CTCF> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CTCF)" .
<http://www.openbel.org/bel/p_HGNC_SKP1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//SKP1> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasModificationType> <http://www.openbel.org/vocabulary/Phosphorylation> .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/cat_p_HGNC_KITLG> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/p_HGNC_TNFRSF10A> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//TNFRSF10A> .
<http://www.openbel.org/bel/p_MGI_Jup_Decreases_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Jup) decreases p(MGI:Myc)" .
<http://www.openbel.org/bel/r_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/RNAAbundance> .
_:Nd4657abd7a5845c2bbbd4427c19af3aa <http://www.openbel.org/vocabulary/hasEvidenceText> "The Pim-1 and Pim-2 transfectants have lower levels of serine/threonine protein phosphatase 2A (PP2A) activity and the alpha- and beta-subunit B56gamma of the PP2A phosphatase do not coimmunoprecipitate in these cells. Thus, the effects of Pim on PP2A activity may mediate the levels of c-Myc and the phosphorylation of proteins needed for increased protein synthesis." .
<http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_MGI_Pdgfb> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF_DirectlyDecreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyDecreases> .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex> <http://www.w3.org/2000/01/rdf-schema#label> "kin(complex(NCH:\"TORC1 Complex\"))" .
_:N7c1828b18f1a48ad9129432b7d669dc6 <http://www.openbel.org/vocabulary/hasEvidenceText> "Modified assertion" .
<http://www.openbel.org/bel/r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "r(HGNC:MYC)" .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Enzastaurin%20Hydrochloride> .
<http://www.openbel.org/bel/complex_NCH_Nfkb_Complex> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Nfkb%20Complex> .
<http://www.openbel.org/bel/cat_p_HGNC_KITLG> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Catalytic> .
_:Ncdb783d15692446791fcec50f914b8d4 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex_DirectlyIncreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_cell_proliferation> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases bp(GO:\"cell proliferation\")" .
_:N06a1bd32a94f4ce2a1c46e7dbb0432ec <http://www.openbel.org/vocabulary/hasEvidenceText> "TABLE 2  Distinct alterations in gene expression induced by lovastatin, simvastatin, or pravastatin in the cerebral cortex of C57BL/6 mice" .
<http://www.openbel.org/bel/r_HGNC_PLD2> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//PLD2> .
_:N5415688460f243b2a95ffe04963f4de6 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_RB1_pmod_P_S_780> <http://www.openbel.org/vocabulary/hasEvidence> _:N40e0a75abd734a27b75f90db3110fb63 .
<http://www.openbel.org/bel/p_HGNC_RPL11_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/tscript_p_HGNC_MNT> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_ATF2_pmod_P_T_51> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases p(HGNC:ATF2,pmod(P,T,51))" .
<http://www.openbel.org/bel/cat_p_HGNC_TNFRSF10A> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Catalytic> .
<http://www.openbel.org/bel/p_HGNC_BCL2L11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:N07400840bde944cd8f2639a0f0b26987 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15358814> .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus_Decreases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:Sirolimus) decreases p(HGNC:MYC)" .
<http://www.openbel.org/bel/a_CHEBI_simvastatin> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:simvastatin)" .
<http://www.openbel.org/bel/p_HGNC_HBP1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:HBP1)" .
<http://www.openbel.org/bel/a_CHEBI_calcitriol> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//calcitriol> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC_DirectlyDecreases_tscript_p_HGNC_ZBTB17> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_ZBTB17> .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/a_CHEBI_simvastatin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia_Decreases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"response to hypoxia\") decreases p(HGNC:MYC)" .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:N43bca9610845459aa0fc35e6b5e6585e <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16467374> .
<http://www.openbel.org/bel/p_HGNC_SNIP1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:SNIP1)" .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1_Increases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N192e8a2947d64c3faae01fe81fb1d02d <http://www.openbel.org/vocabulary/hasEvidenceText> "Table S2. Other responsive genes are deregulated by enzastaurin in U251, as detected by Anova and Ingenuity Pathway Analysis software, shown in Tables S2 and S3 respectively. U251 cells were treated in triplicates with 10?M enzastaurin for 10 hours. The initial gene expression analysis data files (CEL files) were generated using Affymetrix GeneChip Operating Software (GCOS) version 1.2. CEL files were processed as described earlier (11). p-value 0.001 and 1.5-fold change were applied as thresholds to select up- or down- regulated probes. " .
<http://www.openbel.org/bel/p_HGNC_CTNNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_tscript_p_HGNC_NFYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_NFYC> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:\"D-Glucose, anhydrous\") increases complex(p(HGNC:MLXIPL),p(HGNC:MYC),p(HGNC:MAX))" .
<http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasEvidence> _:N96fe3997fdf84001b5bfdc20f6be2949 .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40_DirectlyDecreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:BHLHE40)) directlyDecreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/p_HGNC_MXD1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MXD1)" .
<http://www.openbel.org/bel/p_HGNC_RBX1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:RBX1)" .
_:Nd5c3bcf7668747169a3fa949c103cf90 <http://www.openbel.org/vocabulary/hasEvidenceText> "In agreement with the role of S62 phosphorylation on reporter gene expression, the hTERT and Bmi-1 genes were repressed by IFN-? + TPA and by the Cdk2 inhibitor CVT-313 (Fig. 6D), whereas the p21 and p16Ink4A genes were strongly induced (Fig. 6E). The changes in gene expression are consistent with the ChIP results and indicate that cyclin E/Cdk2 enhances, whereas IFN-?, through the activation of p27, represses Myc-activated transcription (and vice versa for Myc-repressed transcription) of genes involved in cellular senescence. " .
_:Nd91b2ea4b1664798b1ba52a351679a82 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18046334> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_HIF1A> .
_:N2cb4acffb5d64d91b5a00ee44dca98af <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11252954> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373> <http://www.openbel.org/vocabulary/hasModificationPosition> "373"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://www.openbel.org/bel/p_HGNC_CTNNB1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CTNNB1> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_calcitriol> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(complex(NCR:\"Nfkb Complex\"))" .
<http://www.openbel.org/bel/complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:MYC),p(HGNC:MAX))" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasEvidence> _:N59eea53535ba43419700e74131aa366a .
<http://www.openbel.org/bel/p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC)" .
<http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:N04aa86ea43684f69b6e76f9d780b8aa9 <http://www.openbel.org/vocabulary/hasEvidenceText> "Expression of Myc inhibits transactivation, overcomes Miz-1-induced growth arrest and renders Miz-1 insoluble in vivo. These processes depend on Myc and Miz-1 association a" .
_:N0ecb500ea2e544b7945f14233e6d2bce <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_linoleic_acid> .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/cat_p_HGNC_TNFRSF10A> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_TNFRSF10A> .
_:Nd5c3bcf7668747169a3fa949c103cf90 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_CCNB1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CCNB1)" .
_:N7a09e7bd1d464289b2e82114d3ffd01d <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16107734> .
_:Ne3380953214047c1a84a91527144916f <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373_DirectlyDecreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_growth> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases bp(GO:\"cell growth\")" .
<http://www.openbel.org/bel/p_HGNC_SKP1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:SKP1)" .
_:N0f53ae1d18d84ffc9fcfd74e12537b12 <http://www.openbel.org/vocabulary/hasEvidenceText> "from full text - Table 2" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_glycolysis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_HGNC_ATF2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_quercetin_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:quercetin) decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/p_HGNC_SKP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_PFH_IFNA_Family> <http://www.w3.org/2000/01/rdf-schema#label> "p(PFH:\"IFNA Family\")" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N991a55aa89994d4ea481e3a143feb4e4 .
<http://www.openbel.org/bel/a_SCHEM_Calcium_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_SCHEM_Calcium> .
_:N7a1c8b294ce14549bd691dbf021859e1 <http://www.openbel.org/vocabulary/hasEvidenceText> "Downregulated genes at both time-points were: IL2RA, CMYC, NPM, DEK, AF4, FLI1, htlf, MNDA, BCR, IKAROS, BPI and NFAT4. Upregulated genes at both time-points were IL1B, CD14 and MCL1. CD55, CD58, IRF2, CREB1, ATF4, RAC1, TIAR, KIAA0053, BAT2, BTK, RCK, EV12B and EDN were downregulated at 24 h, while SPI1, MKK3, BTG1 and IL8 were upregulated. At 72 h the upregulated genes were IL1RA, IL2RG, CXCR4, SCYA1, SCYA3, SCYA4, SCYA5, SCYA22, ANX2, CD83 and UPAR" .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch_Increases_tscript_p_RGD_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:Nf75048be6fa64a108a04ad5ab0849a41 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_mifepristone_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/bp_GO_cell_proliferation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
_:Nd926613b585a4c58a579e66ac535037f <http://www.openbel.org/vocabulary/hasEvidenceText> "Fig 3. HIF-1? counteracts Myc activity. (A) Effect of ?ODD on Myc transcriptional activity was examined with an hTERT luciferase reporter in HCT116 cells. .....Unlike wild-type HIF-1?, ?ODD constitutively activated HIF-1-mediated reporter gene in transient transfection (Figure 2A). We then inactivated ?ODD transcriptional activity via simultaneous mutations (L795V, C800S, L818S, and L822V) that disrupt p300/CBP binding (Gu et al, 2001; Dames et al, 2002; Freedman et al, 2002). As expected, this ?ODD LCLL mutant was unable to activate the HIF-1 reporter (Figure 2A)." .
_:N1bf5cabc1ef24aef8540926d8edcb184 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18759374> .
<http://www.openbel.org/bel/p_HGNC_HBP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/bp_GO_ribosome_biogenesis> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//ribosome%20biogenesis> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ne391843f2f0048109781ea2a1b20ea9c .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_mifepristone_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"G1/S transition of mitotic cell cycle\")" .
<http://www.openbel.org/bel/bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//G1/S%20transition%20of%20mitotic%20cell%20cycle> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_CDKN2A> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases p(HGNC:CDKN2A)" .
<http://www.openbel.org/bel/p_HGNC_CSNK2A1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CSNK2A1> .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_PFM_Akt_Family> .
<http://www.openbel.org/bel/p_RGD_Pax4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:HNRNPK)" .
<http://www.openbel.org/bel/p_HGNC_CDKN1A> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CDKN1A> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_CDKN2A> <http://www.openbel.org/vocabulary/hasEvidence> _:N54c58219c4da4202a8f5ebfba33222bb .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:PAK2)) directlyDecreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:Nc68955fa98934da0aa220541b5f9336d <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
_:Ncb5569ab91104d02901ba059e4150c2d <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_HOXB13> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:HOXB13)" .
_:Nc1c1f80c854c40c99b3506398153dc4a <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_EGID_5424_Increases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_RPL11_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:RPL11) decreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14_Increases_tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_MAPK14> .
<http://www.openbel.org/bel/kin_p_MGI_Stk11_Decreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Nf7374451a7004cabb76a06f13c45aefd .
<http://www.openbel.org/bel/p_HGNC_HOXB13> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//HOXB13> .
<http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_SCHEM_Calcium> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_glycolysis> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/bp_GO_ribosome_biogenesis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
<http://www.openbel.org/bel/p_HGNC_EGFR> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra_Increases_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(MGI:Il4),p(MGI:Il4ra)) increases p(MGI:Myc)" .
<http://www.openbel.org/bel/bp_GO_cell_proliferation> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"cell proliferation\")" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N17de8600884846c68886039c1a81606c <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_MGI_Stk11> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Stk11)" .
_:N3e72966e42fb40c9bce9ea1f52aeb875 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11910354> .
_:N861eff9ccc14484cac0223d99b2c742b <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_TNFRSF10A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:Ne544f6d3246c4c0dab86782d56fad5e8 <http://www.openbel.org/vocabulary/hasEvidenceText> "Ectopic expression of Myc induces Cdk2 kinaseactivity in quiescent cells and antagonizes association of p27(kip1) with Cdk2." .
<http://www.openbel.org/bel/complex_NCR_Nfkb_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358> <http://www.openbel.org/vocabulary/hasModificationType> <http://www.openbel.org/vocabulary/PhosphorylationThreonine> .
_:N96fe3997fdf84001b5bfdc20f6be2949 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> .
<http://www.openbel.org/bel/complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:MLXIPL),p(HGNC:MYC),p(HGNC:MAX))" .
_:Nba03aff50afb4047b147ec17f756e646 <http://www.openbel.org/vocabulary/hasEvidenceText> "Several of these gene products, including FAS, TRAILR3, PHLDA3, LRDD, and IER3 are previously implicated in the apoptotic death receptor pathway, while others including SESN1, FDXR, PLK3, and DDIT4 are known mediators of reactive oxygen species generation." .
<http://www.openbel.org/bel/p_HGNC_RPL11> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//RPL11> .
_:N6f6b239300ec4eaebf127678482c805f <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasEvidence> _:N0f53ae1d18d84ffc9fcfd74e12537b12 .
<http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:progesterone) increases r(HGNC:MYC)" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_glycolysis> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_glycolysis> .
_:Nb5563ff8e8b54adb9469097102d70b07 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15723053> .
<http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Pdgfb) increases p(MGI:Myc)" .
<http://www.openbel.org/bel/p_PFH_IFNA_Family_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(PFH:\"IFNA Family\") decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/p_HGNC_BHLHE40> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:BHLHE40)" .
_:N968a8cf024674412968475a30839b9fc <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4_Increases_r_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_tscript_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_HGNC_ZBTB17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:HIF1A),p(HGNC:MYC))" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:N5a83ea4cdbf34824bc775f1392e7d380 <http://www.openbel.org/vocabulary/hasEvidenceText> "the protein products of at least 3 nuclear protooncognes, MYC, FOS and JUN, are also induced by both estrogen and progesterone in breast cancer" .
_:Nbfa807e779c245489c621cd74e5b68e5 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_tscript_p_HGNC_MYC_pmod_P> .
_:N4f1cb21104a64cf8af17702a53851d22 <http://www.openbel.org/vocabulary/hasEvidenceText> "Modified assertion" .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Ne8fa4e913ac84cd99607fd5d14d402c8 .
<http://www.openbel.org/bel/tscript_p_HGNC_ATF2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_ATF2> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_PAK2> .
_:Naec820bea73a4ab68c10591102ddeeec <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:20043278> .
<http://www.openbel.org/bel/kin_p_EGID_5424_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(EGID:5424)) increases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/a_SCHEM_Estrogens> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Estrogens> .
<http://www.openbel.org/bel/p_HGNC_HIF1A> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:HIF1A)" .
_:Ncd484cf247514b63b5b2570c63ed7e03 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_troglitazone_Increases_r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nff338c2d1dbc471da136c58c35011d22 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_cell_proliferation> .
<http://www.openbel.org/bel/p_MGI_Pim1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Pim1> .
<http://www.openbel.org/bel/a_SCHEM_Estrogens> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:N6f7d84eee3ae4a539598fb6c5868f4e1 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_DNA_replication> .
_:Nc4adff57295649dc82e5f07f2aba2ca1 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11018017> .
<http://www.openbel.org/bel/p_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nd3730d8191f2468fbbf54c05eb80e43a <http://www.openbel.org/vocabulary/hasEvidenceText> "Further, Myc-induced transcription was shown to be Skp2 dependent, suggestinginterdependence between c-Myc and Skp2 in activation of transcription. Moreover,Myc-dependent association of Skp2, ubiquitylated proteins, and subunits of theproteasome to a c-Myc target promoter was demonstrated in vivo. The resultssuggest that Skp2 is a transcriptional cofactor for c-Myc and indicates a closerelationship between transcription activation and transcription factorubiquitination." .
_:Ncd484cf247514b63b5b2570c63ed7e03 <http://www.openbel.org/vocabulary/hasEvidenceText> "Troglitazone significantly increased the expression of c-myc messenger RNA but had no effect on the expression of bcl-2 and bax in thyroid carcinoma cells." .
_:Nbdedc3d6738a410a8fdc1e79532c9008 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16107734> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/2000/01/rdf-schema#label> "kin(complex(NCH:\"p85/p110 PI3Kinase Complex\")) increases p(HGNC:MYC,pmod(P,S,62))" .
_:N96892952b7fe40afaa317426816bc84f <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P_DirectlyIncreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_MGI_Myc_pmod_P> .
_:N9ad974896fae4850ad39640dbce741e3 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N68658d4f610c43e987847c3e04627376 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> .
_:Ne53720177d19481684179086b66d1826 <http://www.openbel.org/vocabulary/hasEvidenceText> "Phosphorylation by Pak2 inhibits the ability of Myc to activate transcription" .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/p_HGNC_ATF2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/r_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/RNAAbundance> .
_:Nff338c2d1dbc471da136c58c35011d22 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> .
<http://www.openbel.org/bel/tscript_p_HGNC_ZBTB17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N65156ac8ae414741865c2e3745d2ec28 <http://www.openbel.org/vocabulary/hasEvidenceText> "TABLE 2 Distinct alterations in gene expression induced by lovastatin, simvastatin, or pravastatin in the cerebral cortex of C57BL/6 mice " .
<http://www.openbel.org/bel/p_HGNC_SNIP1_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
<http://www.openbel.org/bel/a_CHEBI_cisplatin_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_EGID_5243> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases p(EGID:5243)" .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/p_HGNC_ZBTB17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Nec20c03a78ba4826942fb08ea85c9bca <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_MESHPP_Apoptosis> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:ROCK1)) increases p(HGNC:MYC,pmod(P,S,62))" .
_:N504fd9010a0a4f448ce9a271465d15fe <http://www.openbel.org/vocabulary/hasEvidenceText> "Table S2. Other responsive genes are deregulated by enzastaurin in U251, as detected by Anova and Ingenuity Pathway Analysis software, shown in Tables S2 and S3 respectively. U251 cells were treated in triplicates with 10?M enzastaurin for 4 hours. The initial gene expression analysis data files (CEL files) were generated using Affymetrix GeneChip Operating Software (GCOS) version 1.2. CEL files were processed as described earlier (11). p-value 0.001 and 1.5-fold change were applied as thresholds to select up- or down- regulated probes." .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_DirectlyIncreases_p_HGNC_MYC_pmod_P_T_58> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_cell_proliferation> .
_:Nc1c1f80c854c40c99b3506398153dc4a <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N6f7d84eee3ae4a539598fb6c5868f4e1 <http://www.openbel.org/vocabulary/hasEvidenceText> "Overexpression of c-Myc causes increased replication origin activity with subsequent DNA damage and checkpoint activation." .
_:Ne3380953214047c1a84a91527144916f <http://www.openbel.org/vocabulary/hasEvidenceText> "Phosphorylation by Pak2 inhibits the ability of Myc to activate transcription" .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases complex(p(HGNC:CDKN1B),p(HGNC:CDK4),p(HGNC:CCND2))" .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N1be098f802b84302aa9d55284ed8a034 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16179914> .
<http://www.openbel.org/bel/a_CHEBI_troglitazone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_troglitazone> .
<http://www.openbel.org/bel/p_HGNC_TNFRSF10A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/bp_MESHPP_Apoptosis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_mifepristone> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nf3d25589d44449fda7a9282f1c834cdc <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_SCHEM_Estrogens_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N7a09e7bd1d464289b2e82114d3ffd01d .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:N03ecb4fdeb764d2da42e7cdebdbae812 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N59eea53535ba43419700e74131aa366a <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16530485> .
<http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_ribosome_biogenesis> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_cisplatin_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_CDK3> .
_:N90ae420ed2af403a80cc85d60a763c84 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> .
_:Nf75048be6fa64a108a04ad5ab0849a41 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:17584828> .
_:N504fd9010a0a4f448ce9a271465d15fe <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nf5e8af358b43401584456575f9257671 .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:BHLHE40))" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX> .
<http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Nbd03c7b0b958436b9acda3c1053fe3f7 .
<http://www.openbel.org/bel/p_MGI_Pdgfb> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MAX)" .
<http://www.openbel.org/bel/a_CHEBI_ceramide_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_ceramide> .
_:N5bd7cc23bf19422d83fa2bae40a7113d <http://www.openbel.org/vocabulary/hasEvidenceText> "Furthermore, when HL-60 myeloid leukemic cells were differentiated with phorbol ester (TPA), PBK/TOPK protein expression was strongly down-regulated by 24 h. Under these same conditions, phosphorylated c-Myc was rapidly down-regulated (by 4 h), while the levels of cyclin D1 and phosphorylated p38 were constant." .
<http://www.openbel.org/bel/tscript_p_HGNC_ATF2> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N6df102a43ca3429abb919162b7cd1be0 .
<http://www.openbel.org/bel/p_MGI_Pim1> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Pim1)" .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK_Increases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:SRC))" .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N59cd8722e1ce4fe9aba087d6f15cc645 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Naec820bea73a4ab68c10591102ddeeec <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(complex(p(HGNC:MNT),p(HGNC:MAX)))" .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/bp_GO_response_to_hypoxia> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc_Increases_bp_MESHPP_Apoptosis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_SKP2> .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_tscript_p_HGNC_NFYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) decreases tscript(p(HGNC:NFYC))" .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.openbel.org/vocabulary/hasEvidence> _:Ne544f6d3246c4c0dab86782d56fad5e8 .
<http://www.openbel.org/bel/p_HGNC_MXD1_Decreases_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
_:Nf133596cb14b48c89315c64bb004bc00 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N9ad974896fae4850ad39640dbce741e3 .
_:N6d1fd7c61a6f4dcd9a11bc84226ce633 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16543245> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_KITLG> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_CDKN2A> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_CDKN2A> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_nicotine_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_nicotine> .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40_DirectlyDecreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MXI1_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:Ne8641cf88e324e7eb371d0856d24ada2 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N75afbecbc875479baaee4815523f151d <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_MGI_Myc_Increases_bp_GO_cell_cycle> .
<http://www.openbel.org/bel/tscript_p_HGNC_MNT> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MNT> .
_:N7651448d35c24662bac81822b11eba87 <http://www.openbel.org/vocabulary/hasEvidenceText> "Phosphorylation of downstream mitogen-activated protein kinase-targeted transcription factors including c-Myc, Elk-1, c-Jun, and activating transcription factor (ATF) 2 was also differentially enhanced" .
_:Nfa1009b83fa74bdfa8c1a4853a5f3c98 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC_Increases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_EGID_5424> <http://www.w3.org/2000/01/rdf-schema#label> "p(EGID:5424)" .
<http://www.openbel.org/bel/p_HGNC_MAPK3> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MAPK3)" .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_tscript_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_EGFR> .
_:N17de8600884846c68886039c1a81606c <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_MGI_Myc> .
<http://www.openbel.org/bel/a_CHEBI_quercetin> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//quercetin> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_tscript_p_HGNC_ATF2> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_ATF2> .
<http://www.openbel.org/bel/p_HGNC_CDKN2A> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CDKN2A> .
_:Nf261508663344bee914192fb79b80762 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
_:N3e72966e42fb40c9bce9ea1f52aeb875 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N7a09e7bd1d464289b2e82114d3ffd01d <http://www.openbel.org/vocabulary/hasEvidenceText> "While E2 stimulated a short-term transient increase in Myc expression, E2 stimulated a sustained increase in Myc expression that was detectable at 48 h and pronounced at 5 days, the point where increased proliferation of MCF-7 cells in the absence of serum could be detected." .
_:Nbd03c7b0b958436b9acda3c1053fe3f7 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MNT> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/p_HGNC_MXD1_Decreases_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasEvidence> _:N68658d4f610c43e987847c3e04627376 .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/p_PFH_PRKC_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_MGI_Stk11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:N04aa86ea43684f69b6e76f9d780b8aa9 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC_DirectlyDecreases_tscript_p_HGNC_ZBTB17> .
_:Nce4ece696d424c3cbb74627e43ce56fa <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N6430555704484377b345277534b7b930 <http://www.openbel.org/vocabulary/hasEvidenceText> "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways." .
_:Nb65b6a9148874c2cb5c45f7480c88c84 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16170185> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MXD1_Decreases_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/complex_p_HGNC_MYC_p_HGNC_MAX> .
_:N991a55aa89994d4ea481e3a143feb4e4 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_linoleic_acid_Increases_r_RGD_Myc> .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family_Decreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_MGI_Myc> .
<http://www.openbel.org/bel/p_HGNC_MTA1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/r_MGI_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "r(MGI:Myc)" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_growth> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/a_CHEBI_ceramide_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/p_HGNC_CDK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_ROCK1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_MGI_Myc> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/complex_NCR_Nfkb_Complex> .
_:Ne391843f2f0048109781ea2a1b20ea9c <http://www.openbel.org/vocabulary/hasEvidenceText> "Finally, overexpression of hnRNP K in breast cancer cells significantly increased target c-myc promoter activity and c-Myc protein, hnRNP K protein levels, and enhanced breast cancer cell proliferation and growth in an anchorage-independent manner." .
_:Ne544f6d3246c4c0dab86782d56fad5e8 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Decreases_complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> .
_:N1aaa6a8b46dc4c76a4532df7178d2d43 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/path_SDIS_cyclic_stretch_Increases_tscript_p_RGD_Myc> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_pmod_P> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/bp_GO_response_to_heat_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
_:N247e30732bcc41bcbc2823d914feb665 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11781825> .
_:N0f10fce3502e4fffbc40529f64a83f52 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N75afbecbc875479baaee4815523f151d <http://www.openbel.org/vocabulary/hasEvidenceText> "The c-Myc oncoprotein is strongly induced during the G0 to S-phase transition and is an important regulator of cell cycle entry." .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_CDKN1B> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N7cab6257d5a04b9b8215f4cd55e5c098 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Decreases_tscript_p_HGNC_NFYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_DNA_replication> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_MGI_Pim1_Increases_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_PFH_SMAD_Family> <http://www.w3.org/2000/01/rdf-schema#label> "p(PFH:\"SMAD Family\")" .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CDKN1B> .
<http://www.openbel.org/bel/p_HGNC_NFYC> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//NFYC> .
_:Ncdb783d15692446791fcec50f914b8d4 <http://www.openbel.org/vocabulary/hasEvidenceText> "Activated NF-kB then binds to its consensus sequence and induces the expression of growth factors, cell cycle regulators, and antiapoptotic proteins involved in apoptosis and carcinogenesis. NF-kB targeted genes include but are not limited to Bcl-2, Bcl-xL, EGFR, MMP-2 and ?9, cyclin D1, c-myc, and Cox-2 (128- 134)" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK3)) directlyIncreases p(HGNC:MYC,pmod(P,S,62))" .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//cyclic%20stretch> .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch_Increases_tscript_p_RGD_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_HOXB13_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N968a8cf024674412968475a30839b9fc .
<http://www.openbel.org/bel/a_CHEBI_cisplatin_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:cisplatin) decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/a_CHEBI_progesterone> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MTA1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MTA1)" .
<http://www.openbel.org/bel/p_EGID_5243> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
_:N17de8600884846c68886039c1a81606c <http://www.openbel.org/vocabulary/hasEvidenceText> "Further, Myc-induced transcription was shown to be Skp2 dependent, suggesting interdependence between c-Myc and Skp2 in activation of transcription." .
_:N5a83ea4cdbf34824bc775f1392e7d380 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK3)) increases p(HGNC:MYC)" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_MAPK3> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_EGID_5243> <http://www.w3.org/2000/01/rdf-schema#label> "p(EGID:5243)" .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_HIF1A> .
_:N03ecb4fdeb764d2da42e7cdebdbae812 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> .
_:N54c58219c4da4202a8f5ebfba33222bb <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nab5656c22f054e01bfdce740e2cfacc4 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10207076> .
_:N690b4bc8be04411cae73180bb765d47b <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_ATF2_pmod_P_T_51> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:Nff338c2d1dbc471da136c58c35011d22 .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_nicotine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
_:N44f8154ac7d04538b58a853d2bba45f8 <http://www.openbel.org/vocabulary/hasEvidenceText> "These findings support a model where Mnt represses Myc target genes and Myc functions as an oncogene by relieving Mnt-mediated repression." .
<http://www.openbel.org/bel/bp_GO_glycolysis> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:glycolysis)" .
_:Nccbe5facd42a4c4986b9ffaf6125ac61 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18032916> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc_Increases_bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_MESHPP_Apoptosis> .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex_Increases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(complex(NCH:\"TORC1 Complex\")) increases p(HGNC:MYC)" .
<http://www.openbel.org/bel/p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_ZBTB17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/cat_p_HGNC_TNFRSF10A> <http://www.w3.org/2000/01/rdf-schema#label> "cat(p(HGNC:TNFRSF10A))" .
<http://www.openbel.org/bel/complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_mifepristone_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:mifepristone) decreases r(HGNC:MYC)" .
_:N192e8a2947d64c3faae01fe81fb1d02d <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nce4ece696d424c3cbb74627e43ce56fa <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10801075> .
<http://www.openbel.org/bel/p_HGNC_SNIP1_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_SNIP1> .
<http://www.openbel.org/bel/a_SCHEM_Estrogens_Increases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_58> <http://www.openbel.org/vocabulary/hasModificationPosition> "58"^^<http://www.w3.org/2001/XMLSchema#integer> .
_:N404334d1c59844e187533083267e7bd3 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:CTCF))" .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_SRC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N2cb4acffb5d64d91b5a00ee44dca98af .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N5bd7cc23bf19422d83fa2bae40a7113d <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N4f1cb21104a64cf8af17702a53851d22 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/bp_GO_cell_growth> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
<http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_tscript_p_HGNC_NFYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_PFH_SMAD_Family> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//SMAD%20Family> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasEvidence> _:N690e05d73f194492ae44aa58eec8ee97 .
<http://www.openbel.org/bel/bp_GO_DNA_replication> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"DNA replication\")" .
_:N6f0f4a245ce6448ab1bdf8b7ccc505a9 <http://www.openbel.org/vocabulary/hasEvidenceText> "Modified assertion" .
_:Nc4adff57295649dc82e5f07f2aba2ca1 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MNT> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MNT> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nc63dbab7e50b4d019376214a8b01e545 .
<http://www.openbel.org/bel/p_HGNC_KITLG> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:KITLG)" .
_:N26a979e9013545c7ae735eb91da0b474 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N68658d4f610c43e987847c3e04627376 <http://www.openbel.org/vocabulary/hasEvidenceText> "Incubation of Caco2 cells in hypoxia increased the phosphorylation of c-Myc, and this was blocked when both PI3K and ROCK were specifically inhibited (Fig. 4D). " .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasEvidence> _:Nc4adff57295649dc82e5f07f2aba2ca1 .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> .
_:N03ecb4fdeb764d2da42e7cdebdbae812 <http://www.openbel.org/vocabulary/hasEvidenceText> "We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK." .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_progesterone> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_HNRNPK> .
<http://www.openbel.org/bel/tscript_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_MGI_Jup> <http://www.w3.org/2000/01/rdf-schema#label> "p(MGI:Jup)" .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous> .
_:N690b4bc8be04411cae73180bb765d47b <http://www.openbel.org/vocabulary/hasEvidenceText> "Regions of the c-myc protein required for induction of apoptosis overlap with regions necessary for cotransformation, autoregulation, and inhibition of differentiation, suggesting that the apoptotic function of c-myc protein is related to its other functions." .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N7966c306f2c64214871a677eed78476b <http://www.openbel.org/vocabulary/hasEvidenceText> "CD40 signaling also acts to suppress the expression of the gene encoding CTCF, which is a transcription factor that represses c-myc expression, thus allowing sustained c-myc expression and cell cycle progression" .
<http://www.openbel.org/bel/p_HGNC_SKP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P> .
<http://www.openbel.org/bel/p_MGI_Il4ra> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Il4ra> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC_Increases_p_HGNC_CDKN1A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_ATF2_pmod_P_T_51> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:ATF2,pmod(P,T,51))" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK1)) directlyIncreases p(HGNC:MYC,pmod(P,S,62))" .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/kin_p_HGNC_ROCK1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_ceramide_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N1562ff788316497a9c6f77a7c3d0b751 .
<http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N17de8600884846c68886039c1a81606c .
<http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:SKP2) directlyIncreases tscript(p(HGNC:MYC))" .
_:N4f1cb21104a64cf8af17702a53851d22 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10970882> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK1)) increases tscript(p(HGNC:MYC))" .
_:Nf261508663344bee914192fb79b80762 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Sirolimus_Decreases_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_BHLHE40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
_:N6ae3fe5c170b41b0a170612fef2c450e <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_HIF1A> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//HIF1A> .
<http://www.openbel.org/bel/path_SDIS_laminar_shear_stress_Increases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "path(SDIS:\"laminar shear stress\") increases r(HGNC:MYC)" .
<http://www.openbel.org/bel/tscript_p_HGNC_CTCF> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N40f19a5d5afe4e90bf57b776da642e32 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/p_HGNC_MAPK14> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_RGD_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "p(RGD:Myc)" .
<http://www.openbel.org/bel/cat_p_HGNC_KITLG> <http://www.w3.org/2000/01/rdf-schema#label> "cat(p(HGNC:KITLG))" .
_:N0f53ae1d18d84ffc9fcfd74e12537b12 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:19221497> .
_:N44f8154ac7d04538b58a853d2bba45f8 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/cat_p_HGNC_SKP2> <http://www.w3.org/2000/01/rdf-schema#label> "cat(p(HGNC:SKP2))" .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(RGD:Pax4))" .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_EGFR> .
<http://www.openbel.org/bel/p_HGNC_CSNK2A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Nfe6b9fc05c38404a9768fcef6fe603d0 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16172399> .
<http://www.openbel.org/bel/cat_p_HGNC_SKP2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_nicotine_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N40f19a5d5afe4e90bf57b776da642e32 .
<http://www.openbel.org/bel/a_CHEBI_mifepristone> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//mifepristone> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:SKP2),p(HGNC:MYC))" .
_:N9d5da96e083e4321b246f785ec11de5b <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_PFM_Foxo_Family> <http://www.w3.org/2000/01/rdf-schema#label> "p(PFM:\"Foxo Family\")" .
_:Nb948ad18b56c4f8092149f85b8ebba58 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch_Increases_tscript_p_RGD_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "path(SDIS:\"cyclic stretch\") increases tscript(p(RGD:Myc))" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373> .
_:N1e07c28a80644063b64f6213446312f3 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N4f9ed8d0384e4c9ab74ffa05dc267cbf <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16210249> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia> <http://www.w3.org/2000/01/rdf-schema#label> "bp(GO:\"response to hypoxia\")" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P,T,358)) directlyDecreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_TNFRSF10A> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases cat(p(HGNC:TNFRSF10A))" .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//fulvestrant> .
<http://www.openbel.org/bel/p_HGNC_CUL1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_EGID_5424> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC_Increases_p_HGNC_CDKN1A> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_CDKN1A> .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:N07400840bde944cd8f2639a0f0b26987 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_SCHEM_Estrogens> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/tscript_p_MGI_Myc_Increases_bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_MGI_Myc> .
_:N9f3f10819d86471ba2ffa7dc41a7d82b <http://www.openbel.org/vocabulary/hasEvidenceText> "Ectopic cdk3, but not cdk2, enhances Myc-induced proliferation and anchorage-independent growth associated with Myc activation, without effects on cyclin D1, E and A protein expression or kinase activities. " .
<http://www.openbel.org/bel/p_HGNC_CDK4> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CDK4> .
_:Nf3d25589d44449fda7a9282f1c834cdc <http://www.openbel.org/vocabulary/hasEvidenceText> "It has been reported that during the G1 to S transition of the cell cycle, Skp2 regulates the ubiquitinylation and stability of the transcription factor c-Myc, an oncoprotein that plays a major role in oncogenesis Skp2 enhances c-Myc-induced S phase transition and activates c-Myc transcriptional activity." .
_:N690e05d73f194492ae44aa58eec8ee97 <http://www.openbel.org/vocabulary/hasEvidenceText> "Glucose increased c-Myc abundance and association with its heterodimer partner Max. Manipulations that prevented the formation of a functional c-Myc/Max heterodimer reduced the expression of the L-PK gene. In addition, glucose augmented the binding of ChREBP, c-Myc, and Max to the promoter of the L-PK gene in situ.  #[JL] Chrebp is MLXIPL, and is implicated as a glucose-responsive factor.  This is basically saying that glucose activates MLXIPL- activation of MYC" .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_CDK4> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_BCL2L11> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases p(HGNC:BCL2L11)" .
_:N648dc396fdc24ea2a04b2d595f383f8f <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_CUL1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CUL1)" .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_tscript_p_HGNC_NFYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:Nd4657abd7a5845c2bbbd4427c19af3aa <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Pim1_Increases_p_MGI_Myc> .
_:Nf6e71c69e6ca4c44a4d2190c54b15561 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_DirectlyIncreases_p_HGNC_MYC_pmod_P_T_58> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:GSK3B)) directlyIncreases p(HGNC:MYC,pmod(P,T,58))" .
<http://www.openbel.org/bel/p_HGNC_PAK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_RPL11_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_RPL11> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK14))" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373> <http://www.openbel.org/vocabulary/hasModificationType> <http://www.openbel.org/vocabulary/PhosphorylationSerine> .
<http://www.openbel.org/bel/a_CHEBI_cisplatin> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//cisplatin> .
<http://www.openbel.org/bel/kin_p_EGID_5424_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nc1c1f80c854c40c99b3506398153dc4a .
<http://www.openbel.org/bel/a_SCHEM_Calcium_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
_:N988ed9057f6143b9b4c5764238499138 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16234270> .
<http://www.openbel.org/bel/r_RGD_Myc> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Myc> .
_:N4f9ed8d0384e4c9ab74ffa05dc267cbf <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N7cab6257d5a04b9b8215f4cd55e5c098 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N96fe3997fdf84001b5bfdc20f6be2949 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nce4ece696d424c3cbb74627e43ce56fa <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_PFH_PRKC_Family_Increases_r_HGNC_MYC> .
_:Nb7dbd5320a3d405eabcb34d4ed955d8a <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:17373752> .
_:Nbd03c7b0b958436b9acda3c1053fe3f7 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Tgfb1_Decreases_p_MGI_Myc> .
<http://www.openbel.org/bel/kin_p_MGI_Stk11_Decreases_tscript_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex_Increases_r_RGD_Myc> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_RGD_Myc> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:\"Enzastaurin Hydrochloride\") decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_CHEBI_troglitazone_Increases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:troglitazone) increases r(HGNC:MYC)" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_G1/S_transition_of_mitotic_cell_cycle> .
_:N192e8a2947d64c3faae01fe81fb1d02d <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18701488> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P> .
<http://www.openbel.org/bel/r_HGNC_PLD2> <http://www.w3.org/2000/01/rdf-schema#label> "r(HGNC:PLD2)" .
<http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:ROCK2) decreases p(HGNC:MYC)" .
<http://www.openbel.org/bel/a_CHEBI_quercetin> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:quercetin)" .
<http://www.openbel.org/bel/a_CHEBI_mifepristone> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
_:N76753b3dfcbf442cb26076f384561ac6 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nab5656c22f054e01bfdce740e2cfacc4 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Myc_Increases_bp_GO_cell_proliferation> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MAX_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:HIF1A),p(HGNC:MAX)) decreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_EGID_5243> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_EGID_5243> .
_:N00a98f5d04cd47d5bda1c6a9eeb72d6c <http://www.openbel.org/vocabulary/hasEvidenceText> "Pharmacologic inhibition of CK2 activity in cell lines established from CK2alpha transgenic T cell lymphomas reduces their proliferation and concomitantly with this, the steady state levels of c-myc protein decline. This is caused by accelerated c-myc protein turnover, which occurs in a proteasome-dependent manner." .
_:N8d1ddfc4ebc34fa78cd22c6920f29de5 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16543245> .
<http://www.openbel.org/bel/p_PFH_SMAD_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_SCHEM_Calcium_Increases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(SCHEM:Calcium) increases r(HGNC:MYC)" .
<http://www.openbel.org/bel/kin_p_EGID_5424_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_EGID_5424> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_EGID_2475> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_EGID_2475> .
<http://www.openbel.org/bel/a_CHEBI_quercetin_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:Nd84b73e335c649f18bf475105af33b03 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40_DirectlyDecreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
_:Nef31cf3d9a0d41a49de1121ddaccfcf6 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:11045257> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_MAPK1> .
_:N247e30732bcc41bcbc2823d914feb665 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/cat_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_SKP2> .
<http://www.openbel.org/bel/p_HGNC_CSNK2A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N40e0a75abd734a27b75f90db3110fb63 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15489884> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_PAK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_RB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P> .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Ndd710746cfbd4e6bbc1dc8bc7835ec34 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_HGNC_PAK2_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N6f0f4a245ce6448ab1bdf8b7ccc505a9 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P> <http://www.openbel.org/vocabulary/hasModificationType> <http://www.openbel.org/vocabulary/Phosphorylation> .
_:N1562ff788316497a9c6f77a7c3d0b751 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_RB1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//RB1> .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_BHLHE40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/complex_NCH_TORC1_Complex> <http://www.w3.org/2000/01/rdf-schema#label> "complex(NCH:\"TORC1 Complex\")" .
_:Ndd710746cfbd4e6bbc1dc8bc7835ec34 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16467374> .
<http://www.openbel.org/bel/p_HGNC_HNRNPK> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//HNRNPK> .
<http://www.openbel.org/bel/r_HGNC_PLD2_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nbdedc3d6738a410a8fdc1e79532c9008 .
<http://www.openbel.org/bel/a_CHEBI_cisplatin_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:N6df102a43ca3429abb919162b7cd1be0 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_fulvestrant_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_CDK2> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CDK2)" .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nd91b2ea4b1664798b1ba52a351679a82 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MXI1_Decreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nff338c2d1dbc471da136c58c35011d22 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9569019> .
_:N80f1328034b84745a8d8c7bdb891842e <http://www.openbel.org/vocabulary/hasEvidenceText> "plakoglobin-mediated suppression of the pro-proliferative proto-oncogene c-Myc, which is critical for growth inhibition in these cells (Arnold and Watt, 2001; Waikel et al., 2001; Kolly et al., 2005; Figure 2)." .
<http://www.openbel.org/bel/kin_p_MGI_Stk11_Decreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_MGI_Stk11> .
_:Nba42f14b886b47ce9309e4fb31728883 <http://www.openbel.org/vocabulary/hasEvidenceText> "MYC overexpression enhances glycolysis without hypoxia and hence may contribute to altered tumor metabolism. Because the full spectrum of glycolytic genes directly regulated by Myc is not known, we chose Myc as a model transcription factor to determine whether it binds target glycolytic genes that have conserved canonical Myc binding sites or E boxes" .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_kin_p_HGNC_CDK2> <http://www.openbel.org/vocabulary/hasEvidence> _:N940f4d10508044188ff15ee88bacd91a .
_:Nb948ad18b56c4f8092149f85b8ebba58 <http://www.openbel.org/vocabulary/hasEvidenceText> "From Cell Signaling Technologies Pathway Maps for p38 and JNK signaling." .
<http://www.openbel.org/bel/bp_GO_response_to_heat_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/bp_GO_response_to_heat> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_SKP1> .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40_DirectlyDecreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/tscript_p_HGNC_NFYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_BHLHE40> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_MGI_Jup_Decreases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N80f1328034b84745a8d8c7bdb891842e .
_:N17de8600884846c68886039c1a81606c <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12769844> .
_:N555ffda1fd51462eb070a86fb398a693 <http://www.openbel.org/vocabulary/hasEvidenceText> "Interleukin 2 (IL-2)- and IL-4-mediated stimulation of survival and growth, reflected by the induction of bcl2 and c-myc, respectively, depends on the integrity of the membrane-proximal region (S-region) in the IL-2 receptor beta-chain (IL-2R beta) and the haematopoietin homology box1-containing region of the IL-4 receptor alpha-chain (IL-4R alpha)." .
<http://www.openbel.org/bel/tscript_p_PFM_Foxo_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_373> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_BCL2L11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_ZBTB17> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//ZBTB17> .
_:N9eec22bf1a854532974c8f337a008a1e <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> .
<http://www.openbel.org/bel/a_CHEBI_ceramide> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//ceramide> .
_:N04aa86ea43684f69b6e76f9d780b8aa9 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9312026> .
_:N690b4bc8be04411cae73180bb765d47b <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_RGD_Myc_Increases_bp_MESHPP_Apoptosis> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:CDK3))" .
<http://www.openbel.org/bel/p_HGNC_SNIP1_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:SNIP1) directlyIncreases tscript(p(HGNC:MYC))" .
_:N861eff9ccc14484cac0223d99b2c742b <http://www.openbel.org/vocabulary/hasEvidenceText> "siRNAs that inhibit or enhance DR4- or DR5-mediated cell death" .
<http://www.openbel.org/bel/tscript_p_HGNC_ATF2> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:ATF2))" .
<http://www.openbel.org/bel/complex_p_HGNC_SKP1_p_HGNC_CUL1_p_HGNC_RBX1_p_HGNC_SKP2_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:Nf6e71c69e6ca4c44a4d2190c54b15561 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12769844> .
_:N9f3f10819d86471ba2ffa7dc41a7d82b <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_CDK3_Increases_tscript_p_HGNC_MYC> .
_:N43bca9610845459aa0fc35e6b5e6585e <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:CDKN1B),p(HGNC:CDK4),p(HGNC:CCND2))" .
<http://www.openbel.org/bel/a_CHEBI_nicotine_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:N59eea53535ba43419700e74131aa366a <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_cell_proliferation> .
_:N6f7d84eee3ae4a539598fb6c5868f4e1 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/r_HGNC_PLD2_Increases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_PFM_Akt_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_ribosome_biogenesis> <http://www.openbel.org/vocabulary/hasEvidence> _:N30a68934867f4b448b158b94f339afd7 .
<http://www.openbel.org/bel/p_HGNC_EGFR> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:EGFR)" .
<http://www.openbel.org/bel/a_CHEBI_fulvestrant> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N1db0146e2ed34be1a5e5b9734bd3e990 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//p85/p110%20PI3Kinase%20Complex> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_CHEBI_calcitriol> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Ne53720177d19481684179086b66d1826 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14749374> .
<http://www.openbel.org/bel/p_PFH_IFNA_Family_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_PFH_IFNA_Family> .
_:Nbdedc3d6738a410a8fdc1e79532c9008 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nc68955fa98934da0aa220541b5f9336d <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> .
_:Ndab32b1d8d7f46aa88429464f43c2441 <http://www.openbel.org/vocabulary/hasEvidenceText> "Table 9. Non-HSP genes most strongly downregulated by EHI" .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_complex_p_HGNC_CDKN1B_p_HGNC_CDK2_p_HGNC_CCNB1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N1aaa6a8b46dc4c76a4532df7178d2d43 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N7651448d35c24662bac81822b11eba87 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Na98752b5db4e47bf9bab6d2e9149f448 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nf261508663344bee914192fb79b80762 <http://www.openbel.org/vocabulary/hasEvidenceText> "The signalling inhibitors rapamycin and wortmannin blocked the phosphorylation of 4E-BP1 and abolished the translational component of the c-myc response. " .
<http://www.openbel.org/bel/bp_GO_cell_proliferation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MNT> .
_:N40e0a75abd734a27b75f90db3110fb63 <http://www.openbel.org/vocabulary/hasEvidenceText> "The effects of short interfering RNA (siRNA)-mediated downregulation of Id1 were the same as those following downregulation of c-Myc: decreased expression of cyclins D1 and E, reduced phosphorylation of pRb at Ser780 (a site targeted by cyclin D1-Cdk4) and reduced cyclin E-Cdk2 activity" .
_:Ne3380953214047c1a84a91527144916f <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_MGI_Myc_Increases_bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_cell_cycle> .
<http://www.openbel.org/bel/bp_GO_DNA_replication> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_growth> <http://www.openbel.org/vocabulary/hasEvidence> _:Nb5563ff8e8b54adb9469097102d70b07 .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC_DirectlyDecreases_tscript_p_HGNC_ZBTB17> <http://www.openbel.org/vocabulary/hasEvidence> _:N04aa86ea43684f69b6e76f9d780b8aa9 .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(HGNC:MAPK3)) increases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_p_HGNC_ZBTB17> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_tscript_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_pmod_P> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC_Increases_p_HGNC_CDKN1A> <http://www.w3.org/2000/01/rdf-schema#label> "complex(p(HGNC:HIF1A),p(HGNC:MYC)) increases p(HGNC:CDKN1A)" .
<http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_MESHPP_Apoptosis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous> .
<http://www.openbel.org/bel/a_CHEBI_mifepristone> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:mifepristone)" .
_:N04aa86ea43684f69b6e76f9d780b8aa9 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nc6803fc006034e12bc5bf37b359855c6 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Pdgfb_Increases_p_MGI_Myc> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
_:Nf75048be6fa64a108a04ad5ab0849a41 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_SKP2_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MYC> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:Ne8641cf88e324e7eb371d0856d24ada2 <http://www.openbel.org/vocabulary/hasEvidenceText> "Figure 1 | The ErbB signalling network." .
_:N7966c306f2c64214871a677eed78476b <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:N404334d1c59844e187533083267e7bd3 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/bp_GO_response_to_hypoxia_Decreases_p_HGNC_MYC> .
<http://www.openbel.org/bel/bp_GO_ribosome_biogenesis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family_Decreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(PFH:\"SMAD Family\")) decreases tscript(p(HGNC:MYC))" .
<http://www.openbel.org/bel/kin_complex_NCH_p85/p110_PI3Kinase_Complex_Increases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> .
<http://www.openbel.org/bel/p_HGNC_CDKN1B> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CDKN1B> .
_:N8953b0211ed04ba99f87050207458cc5 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14517341> .
<http://www.openbel.org/bel/tscript_p_RGD_Pax4> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_RGD_Pax4> .
_:Nd84b73e335c649f18bf475105af33b03 <http://www.openbel.org/vocabulary/hasEvidenceText> "From full text of Table 1 and following up on references in table 1: A list of potential BHLHB2- and BHLHB3-target genes" .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nf261508663344bee914192fb79b80762 .
<http://www.openbel.org/bel/a_CHEBI_troglitazone> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//troglitazone> .
_:N90ae420ed2af403a80cc85d60a763c84 <http://www.openbel.org/vocabulary/hasEvidenceText> "In keratinocytes and mammary epithelial cells, c-MYC downregulation is mediated by a TGF?-induced protein complex containing Smad3/4, p107, E2F4/5, and C/EBP? (Chen et al., 2002; Gomis et al., 2006b)." .
_:N00a98f5d04cd47d5bda1c6a9eeb72d6c <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_CSNK2A1_Increases_p_HGNC_MYC> .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus_Decreases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_EGID_5424> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MAPK3> .
<http://www.openbel.org/bel/kin_p_PFH_PRKC_Family> <http://www.w3.org/2000/01/rdf-schema#label> "kin(p(PFH:\"PRKC Family\"))" .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC_DirectlyDecreases_tscript_p_HGNC_ZBTB17> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Nec20c03a78ba4826942fb08ea85c9bca <http://www.openbel.org/vocabulary/hasEvidenceText> "BCL2 can counteract MYC-induced apoptosis" .
_:N0f53ae1d18d84ffc9fcfd74e12537b12 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_cycle> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/p_HGNC_RPL11_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
_:Nf261508663344bee914192fb79b80762 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:9715279> .
<http://www.openbel.org/bel/p_HGNC_HBP1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//HBP1> .
<http://www.openbel.org/bel/complex_NCR_Nfkb_Complex> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Nfkb%20Complex> .
_:Nbe89666de6be4021aec3ccbe0c24ea1f <http://www.openbel.org/vocabulary/hasEvidenceText> "Immunoblotting revealed that addition of TGF-beta decreased the amount of not only endogenous but also of the retrovirally expressed Myc proteins; whether this is caused by enhanced proteolysis or inhibition of translation is currently unknown (Fig. 1 G)." .
<http://www.openbel.org/bel/a_CHEBI_calcitriol> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:calcitriol)" .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_MGI_Stk11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_ribosome_biogenesis> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC)) increases bp(GO:\"ribosome biogenesis\")" .
_:Ncdb783d15692446791fcec50f914b8d4 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Ncdb783d15692446791fcec50f914b8d4 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14587863> .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra_Increases_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_CDKN1B> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CDKN1B)" .
<http://www.openbel.org/bel/r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Naec820bea73a4ab68c10591102ddeeec <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_CHEBI_mifepristone_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_mifepristone> .
<http://www.openbel.org/bel/p_HGNC_CTNNB1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:CTNNB1)" .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_T_358_DirectlyDecreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_MESHPP_Apoptosis> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases bp(MESHPP:Apoptosis)" .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_DirectlyIncreases_p_HGNC_MYC_pmod_P_T_58> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_GSK3B> .
_:N06a1bd32a94f4ce2a1c46e7dbb0432ec <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15358814> .
<http://www.openbel.org/bel/p_MGI_Il4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Nc4adff57295649dc82e5f07f2aba2ca1 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_MAPK3_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
<http://www.openbel.org/bel/p_PFM_Akt_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nd4657abd7a5845c2bbbd4427c19af3aa <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:16123140> .
_:Nc1c1f80c854c40c99b3506398153dc4a <http://www.openbel.org/vocabulary/hasEvidenceText> "Cells transformed with MYC, but not cells transformed by a panel of other activated oncogenes, rapidly underwent apoptosis when treated with small-molecule CDK1 inhibitors. {Myc transformation and resistance to apoptosis is dependent on its transcriptional activity-SE}" .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK1> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MAPK1> .
_:N65156ac8ae414741865c2e3745d2ec28 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nbd03c7b0b958436b9acda3c1053fe3f7 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18662538> .
<http://www.openbel.org/bel/p_HGNC_RPL11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
_:Nc4adff57295649dc82e5f07f2aba2ca1 <http://www.openbel.org/vocabulary/hasEvidenceText> "We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK." .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_pmod_P> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(HGNC:MYC,pmod(P)))" .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_DirectlyIncreases_p_HGNC_MYC_pmod_P_T_58> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyIncreases> .
<http://www.openbel.org/bel/a_CHEBI_linoleic_acid> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:\"linoleic acid\")" .
<http://www.openbel.org/bel/tscript_p_HGNC_HIF1A> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_complex_NCH_TORC1_Complex> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/complex_NCH_TORC1_Complex> .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
_:N690e05d73f194492ae44aa58eec8ee97 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> .
_:N0f10fce3502e4fffbc40529f64a83f52 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:12044009> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B_Decreases_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/tscript_p_RGD_Myc_Increases_bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasEvidence> _:N690b4bc8be04411cae73180bb765d47b .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_PFM_Akt_Family> .
_:N968a8cf024674412968475a30839b9fc <http://www.openbel.org/vocabulary/hasEvidenceText> "Modified assertion" .
_:N8953b0211ed04ba99f87050207458cc5 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_EGID_2475_Increases_p_HGNC_MYC> .
_:N192e8a2947d64c3faae01fe81fb1d02d <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_GSK3B> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Kinase> .
_:N589e51e4d3874940a9bcb19e3ecb3510 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nb7b63b8575cc4bf29e72d1414150e53a <http://www.openbel.org/vocabulary/hasEvidenceText> "Incubation of Caco2 cells in hypoxia increased the phosphorylation of c-Myc, and this was blocked when both PI3K and ROCK were specifically inhibited (Fig. 4D). " .
<http://www.openbel.org/bel/p_HGNC_HOXB13_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_MTA1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_CDK2> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//CDK2> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_EGID_5243> <http://www.openbel.org/vocabulary/hasEvidence> _:N648dc396fdc24ea2a04b2d595f383f8f .
<http://www.openbel.org/bel/p_HGNC_MAPK1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MAPK1> .
_:N6a8bc81eb3444139a60f4aa73b284a8f <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_MGI_Il4ra> .
_:N76753b3dfcbf442cb26076f384561ac6 <http://www.openbel.org/vocabulary/hasEvidenceText> "We demonstrate that SNIP1 functions as an important regulator of c-Myc activity, binding the N terminus of c-Myc through its own C terminus, and that SNIP1 enhances the transcriptional activity of c-Myc both by stabilizing it against proteosomal degradation and by bridging the c-Myc/p300 complex. " .
<http://www.openbel.org/bel/cat_p_HGNC_TNFRSF10A> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N1db0146e2ed34be1a5e5b9734bd3e990 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:10787179> .
_:N3e72966e42fb40c9bce9ea1f52aeb875 <http://www.openbel.org/vocabulary/hasEvidenceText> "The down-regulated genes include c-myc and c-Met, the hepatocyte growth factor (HGF) receptor. Down-regulation of c-Met is caused by IFN-alpha suppression of the c-Met promoter through down-regulation of Sp1 binding and results in attenuation of HGF-induced signals and cell proliferation. " .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/bp_GO_response_to_heat_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/a_CHEBI_progesterone_Increases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N6ae3fe5c170b41b0a170612fef2c450e .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_cell_proliferation> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_MGI_Myc_pmod_P_DirectlyIncreases_tscript_p_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N7651448d35c24662bac81822b11eba87 .
<http://www.openbel.org/bel/kin_p_PFH_RAF_Family> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/tscript_p_MGI_Myc_Increases_bp_GO_cell_cycle> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(p(MGI:Myc)) increases bp(GO:\"cell cycle\")" .
<http://www.openbel.org/bel/r_HGNC_PLD2_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
_:N96fe3997fdf84001b5bfdc20f6be2949 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18006136> .
<http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "a(CHEBI:\"okadaic acid\") decreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/bp_GO_cell_cycle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N8dd9acc9a4ab4d18be18d81932c22166 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_MYC_Increases_cat_p_HGNC_KITLG> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/kin_p_HGNC_MAPK3> .
_:N940f4d10508044188ff15ee88bacd91a <http://www.openbel.org/vocabulary/hasEvidenceText> "The effects of short interfering RNA (siRNA)-mediated downregulation of Id1 were the same as those following downregulation of c-Myc: decreased expression of cyclins D1 and E, reduced phosphorylation of pRb at Ser780 (a site targeted by cyclin D1-Cdk4) and reduced cyclin E-Cdk2 activity" .
<http://www.openbel.org/bel/p_MGI_Tgfb1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//Tgfb1> .
_:N59cd8722e1ce4fe9aba087d6f15cc645 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_MAPK1_DirectlyIncreases_p_HGNC_MYC_pmod_P_S_62> .
<http://www.openbel.org/bel/a_CHEBI_calcitriol_Decreases_r_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_S_62> .
<http://www.openbel.org/bel/p_HGNC_CTCF> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_MXD1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N76753b3dfcbf442cb26076f384561ac6 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_HGNC_SNIP1_DirectlyIncreases_tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_ZBTB17> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:ZBTB17)" .
_:N07400840bde944cd8f2639a0f0b26987 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_lovastatin_Increases_r_MGI_Myc> .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC_DirectlyDecreases_tscript_p_HGNC_ZBTB17> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/DirectlyDecreases> .
<http://www.openbel.org/bel/a_SCHEM_Tetradecanoylphorbol_acetate_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Decreases> .
<http://www.openbel.org/bel/kin_p_HGNC_EGFR_Increases_p_HGNC_MYC_pmod_P> <http://www.openbel.org/vocabulary/hasEvidence> _:N7c1828b18f1a48ad9129432b7d669dc6 .
<http://www.openbel.org/bel/tscript_p_HGNC_NFYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
_:N75afbecbc875479baaee4815523f151d <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15866886> .
<http://www.openbel.org/bel/bp_GO_DNA_replication> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_MGI_Tgfb1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_CHEBI_troglitazone> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Abundance> .
_:Ndd6d70c4f9ef42348214e7e33692b781 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/bp_GO_response_to_hypoxia> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:Nb948ad18b56c4f8092149f85b8ebba58 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/kin_p_HGNC_MAPK14_Increases_tscript_complex_p_HGNC_MYC_p_HGNC_MAX> .
<http://www.openbel.org/bel/tscript_p_MGI_Myc_Increases_bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasEvidence> _:N75afbecbc875479baaee4815523f151d .
_:Ndd6d70c4f9ef42348214e7e33692b781 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18046334> .
<http://www.openbel.org/bel/p_HGNC_RPL11> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:RPL11)" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_tscript_p_HGNC_ATF2> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_MESHPP_Apoptosis> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_MESHPP_Apoptosis> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK14_Increases_tscript_complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/complex_p_HGNC_HIF1A_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
_:Nccbe5facd42a4c4986b9ffaf6125ac61 <http://www.openbel.org/vocabulary/hasEvidenceText> "Overexpression of L11 inhibits c-Myc-induced transcription and cell proliferation, while reduction of endogenous L11 increases these c-Myc activities. " .
<http://www.openbel.org/bel/p_HGNC_CDK3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_complex_p_HGNC_MNT_p_HGNC_MAX> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/a_SCHEM_Enzastaurin_Hydrochloride_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N504fd9010a0a4f448ce9a271465d15fe .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
_:Nf5e8af358b43401584456575f9257671 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:Nf133596cb14b48c89315c64bb004bc00 <http://www.openbel.org/vocabulary/hasEvidenceText> "A recent study suggests another mechanism by which HIF1? inhibits MYC function through binding MAX and thereby displacing MYC4,48." .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/AbundanceActivity> .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Pathology> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_MTA1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC) increases p(HGNC:MTA1)" .
<http://www.openbel.org/bel/complex_p_MGI_Il4_p_MGI_Il4ra> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_CDK3_Increases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N9f3f10819d86471ba2ffa7dc41a7d82b .
<http://www.openbel.org/bel/p_HGNC_MYC_pmod_P_DirectlyIncreases_tscript_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MYC,pmod(P)) directlyIncreases tscript(p(HGNC:MYC))" .
_:N7b572f44c26e4d0e98024c63906bbd2b <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_RB1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:RB1)" .
<http://www.openbel.org/bel/complex_NCH_p85/p110_PI3Kinase_Complex> <http://www.w3.org/2000/01/rdf-schema#label> "complex(NCH:\"p85/p110 PI3Kinase Complex\")" .
<http://www.openbel.org/bel/p_HGNC_SRC> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//SRC> .
_:N92c663f74d154e1e8399f14d1c119ade <http://www.openbel.org/vocabulary/hasEvidenceText> "The failure of p21waf1 induction, despite increased expression of p53 and its binding to p21waf1 promoter, was mediated by the up-regulation of c-Myc, a negative regulator of p21waf1 transcription. Myc has been shown to bind to the p21waf1 promoter to block its activation on DNA damage" .
<http://www.openbel.org/bel/kin_p_PFM_Akt_Family_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasEvidence> _:N6f0f4a245ce6448ab1bdf8b7ccc505a9 .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N988ed9057f6143b9b4c5764238499138 .
_:Nf6e71c69e6ca4c44a4d2190c54b15561 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
_:N968a8cf024674412968475a30839b9fc <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15126340> .
_:Ndd59d119b4cb47dc95c01ce84efd64c1 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
_:Ncb5569ab91104d02901ba059e4150c2d <http://www.openbel.org/vocabulary/hasEvidenceText> "Ectopic expression of Myc induces Cdk2 kinaseactivity in quiescent cells and antagonizes association of p27(kip1) with Cdk2." .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N1be098f802b84302aa9d55284ed8a034 .
_:N7651448d35c24662bac81822b11eba87 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_MGI_Myc_pmod_P_DirectlyIncreases_tscript_p_MGI_Myc> .
_:N1be098f802b84302aa9d55284ed8a034 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/tscript_p_HGNC_CTNNB1> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
<http://www.openbel.org/bel/tscript_complex_NCH_Nfkb_Complex_DirectlyIncreases_r_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(complex(NCH:\"Nfkb Complex\")) directlyIncreases r(HGNC:MYC)" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/p_PFH_PRKC_Family> <http://www.w3.org/2000/01/rdf-schema#label> "p(PFH:\"PRKC Family\")" .
_:Nb8db20c1ba3a474bb9a946c630e11ad7 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_RB1_pmod_P_S_780> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_S_780> .
<http://www.openbel.org/bel/complex_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MAX> .
<http://www.openbel.org/bel/tscript_p_PFH_SMAD_Family> <http://www.openbel.org/vocabulary/hasActivityType> <http://www.openbel.org/vocabulary/Transcription> .
_:Nc0c83a8b4060423fa6b4be26e87ef4ac <http://www.openbel.org/vocabulary/hasEvidenceText> "FoxO transcription factors suppress Myc-driven lymphomagenesis" .
_:N40f19a5d5afe4e90bf57b776da642e32 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14749372> .
<http://www.openbel.org/bel/complex_NCH_TORC1_Complex> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
_:N988ed9057f6143b9b4c5764238499138 <http://www.openbel.org/vocabulary/hasEvidenceText> "cellular levels of Myc are upregulated by glucose" .
<http://www.openbel.org/bel/p_HGNC_MXI1> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:MXI1)" .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_tscript_p_HGNC_NFYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:N7966c306f2c64214871a677eed78476b <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:15199223> .
_:N8d1ddfc4ebc34fa78cd22c6920f29de5 <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/complex_p_HGNC_MLXIPL_p_HGNC_MYC_p_HGNC_MAX> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/a_CHEBI_calcitriol_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/r_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_ROCK2> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//ROCK2> .
<http://www.openbel.org/bel/complex_p_HGNC_SKP2_p_HGNC_MYC> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ComplexAbundance> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_cycle> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/bp_GO_cell_cycle> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_bp_GO_cell_proliferation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
<http://www.openbel.org/bel/a_SCHEM_Sirolimus> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/cat_p_HGNC_KITLG> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_KITLG> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/p_HGNC_ROCK2_Decreases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_p_HGNC_MTA1> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/p_HGNC_MYC> .
_:N30a68934867f4b448b158b94f339afd7 <http://www.openbel.org/vocabulary/hasEvidenceText> "These results suggest that c-Myc coordinates the activity of all three nuclear RNA polymerases, and thereby plays a key role in regulating ribosome biogenesis and cell growth." .
<http://www.openbel.org/bel/complex_p_HGNC_ZBTB17_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_HGNC_ZBTB17> .
<http://www.openbel.org/bel/p_HGNC_TNFRSF10A> <http://www.w3.org/2000/01/rdf-schema#label> "p(HGNC:TNFRSF10A)" .
<http://www.openbel.org/bel/tscript_p_HGNC_HBP1_Decreases_r_HGNC_MYC> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_HBP1> .
<http://www.openbel.org/bel/a_CHEBI_simvastatin_Increases_r_MGI_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/a_CHEBI_simvastatin> .
<http://www.openbel.org/bel/p_HGNC_HBP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:N59cd8722e1ce4fe9aba087d6f15cc645 <http://www.openbel.org/vocabulary/hasEvidenceText> "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways." .
_:Ne67695a0f36e49b78e704d67e2f6ccd4 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/a_CHEBI_okadaic_acid_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/r_HGNC_PLD2_Increases_p_HGNC_MYC> <http://www.w3.org/2000/01/rdf-schema#label> "r(HGNC:PLD2) increases p(HGNC:MYC)" .
<http://www.openbel.org/bel/p_MGI_Il4ra> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/a_SCHEM_D-Glucose__anhydrous> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Term> .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_bp_GO_cell_cycle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Statement> .
_:Na98752b5db4e47bf9bab6d2e9149f448 <http://www.openbel.org/vocabulary/hasEvidenceText> "TABLE 2 Distinct alterations in gene expression induced by lovastatin, simvastatin, or pravastatin in the cerebral cortex of C57BL/6 mice " .
<http://www.openbel.org/bel/p_HGNC_MYC_Decreases_tscript_p_HGNC_NFYC> <http://www.openbel.org/vocabulary/hasEvidence> _:N7cab6257d5a04b9b8215f4cd55e5c098 .
<http://www.openbel.org/bel/p_HGNC_MTA1> <http://www.openbel.org/vocabulary/hasConcept> <http://www.openbel.org/bel/namespace//MTA1> .
_:Ne391843f2f0048109781ea2a1b20ea9c <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/Evidence> .
<http://www.openbel.org/bel/p_HGNC_RPL11_Decreases_tscript_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasEvidence> _:Nccbe5facd42a4c4986b9ffaf6125ac61 .
<http://www.openbel.org/bel/p_HGNC_MYC_Increases_complex_p_HGNC_CDKN1B_p_HGNC_CDK4_p_HGNC_CCND2> <http://www.openbel.org/vocabulary/hasEvidence> _:N2964e0175fd0472bb9b07b985d46c280 .
<http://www.openbel.org/bel/tscript_complex_NCR_Nfkb_Complex_Increases_r_RGD_Myc> <http://www.w3.org/2000/01/rdf-schema#label> "tscript(complex(NCR:\"Nfkb Complex\")) increases r(RGD:Myc)" .
<http://www.openbel.org/bel/tscript_p_HGNC_MYC_Increases_p_HGNC_BCL2L11> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/tscript_p_HGNC_MYC> .
<http://www.openbel.org/bel/path_SDIS_cyclic_stretch_Increases_tscript_p_RGD_Myc> <http://www.openbel.org/vocabulary/hasSubject> <http://www.openbel.org/bel/path_SDIS_cyclic_stretch> .
_:N1562ff788316497a9c6f77a7c3d0b751 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:18701488> .
<http://www.openbel.org/bel/tscript_p_PFM_Stat5_Family> <http://www.openbel.org/vocabulary/hasChild> <http://www.openbel.org/bel/p_PFM_Stat5_Family> .
<http://www.openbel.org/bel/p_HGNC_SKP1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
_:Ne8fa4e913ac84cd99607fd5d14d402c8 <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:14749374> .
<http://www.openbel.org/bel/r_HGNC_PLD2_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasRelationship> <http://www.openbel.org/vocabulary/Increases> .
<http://www.openbel.org/bel/p_MGI_Jup> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/ProteinAbundance> .
<http://www.openbel.org/bel/bp_GO_response_to_heat> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.openbel.org/vocabulary/BiologicalProcess> .
<http://www.openbel.org/bel/p_PFM_Akt_Family> <http://www.w3.org/2000/01/rdf-schema#label> "p(PFM:\"Akt Family\")" .
_:Ndd710746cfbd4e6bbc1dc8bc7835ec34 <http://www.openbel.org/vocabulary/hasEvidenceText> "Overexpression of LIMK1 leads to down-regulation of Myc, whereas inhibition of Rho kinase, an upstream activator of LIMK1, stimulates Myc expression. " .
_:Nc1c1f80c854c40c99b3506398153dc4a <http://www.openbel.org/vocabulary/hasCitation> <http://bio2rdf.org/pubmed:17589519> .
_:N3e72966e42fb40c9bce9ea1f52aeb875 <http://www.openbel.org/vocabulary/hasStatement> <http://www.openbel.org/bel/p_PFH_IFNA_Family_Decreases_r_HGNC_MYC> .
<http://www.openbel.org/bel/kin_p_HGNC_MAPK3_Increases_p_HGNC_MYC> <http://www.openbel.org/vocabulary/hasObject> <http://www.openbel.org/bel/p_HGNC_MYC> .

